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Polyethylene glycol is one of the most widely used synthetic materials for biomedical 
applications. Its biocompatibility, flexibility, and „stealth‟ properties make it ideal for use in 
drug delivery applications. The main objective of this paper is to characterize the structural and 
mass transfer properties of polyethylene glycol hydrogels for applications in drug delivery and 
biological immobilization. Swelling behavior of the gels was studied to determine the mesh size, 
and other significant structural parameters of the gel. For accurate design of drug delivery 
device, along with network design, mathematical modeling of release profiles was performed.  
The study of PEG hydrogels was done in two distinct phases. The first stage consisted of 
analyzing diffusion properties of homogenous PEG hydrogels with varying molecular weights 
(MW 200, 400, 8000, 10000, 14000, 20000). The release of fluorescein dye from each gel was 
analyzed, and it was observed that diffusive properties of PEG gels vary drastically with 
molecular weight. The lower molecular weight PEGs had lower diffusion coefficients, but their 
Fickian release profile was easy to analyze and predict. The higher molecular weight PEGs, on 
the other hand had large diffusion coefficients, but with anomalous release profiles that were 
difficult to analyze analytically. This led to the investigation of combination gels, or binary 
mixtures of two different molecular weight PEGs. These gels were found to have intermediate 
properties, in accordance with the mass fractions of its constitutive PEGs. This linear 
relationship allowed for development of a hybrid gel with required diffusive properties, and a 




Chapter 1 : An Introduction to Hydrogels 
1.1 Introduction 
Man has always been plagued with ailments and diseases of both the body and the mind. 
However dedicated research from scientists all over the world has made it possible to treat, 
prevent and eradicate many of these diseases that plague man. The field of pharmaceutical 
science has been developing steadily over the years, and has today become invaluable in helping 
to keep us healthy and prevent disease. An avenue of research that has progressed a great deal in 
the past few decades is the treatment of diseases via biomolecules such as drugs, proteins etc. 
Initially these could only be administered in limited manner, due to limitations of drug delivery 
through harmful environments in the body. Thus limited mobility reduced the effectiveness of 
administered drugs [1.16]. Progress came with the development of biomaterial carriers which 
could be encapsulated, or immobilized with drugs, allowing the drug to safely reach the required 
site without harm. These carriers allowed for the release of drug in sites which were previously 
inaccessible. The nature of these carriers progressed over the years from ceramics, to natural, to 
synthetic materials [1.23]. Factors such as integrity, biocompatibility and flexibility were 
considered, and lead to the use of hydrophilic three dimensional matrices as carrier materials. 
These are a class of materials known as Hydrogels. These three dimensional polymer matrices 
are capable of imbibing large amounts of water, and biological fluids. This property of 
hydrogels is the reason behind its varied applications ranging from food additives to 
pharmaceuticals and clinical applications. Synthetic hydrogels prepared from a varied range of 
monomers have found many applications especially in tissue-engineering scaffolds, as carriers 
for implantable devices, and drug delivery devices. Out of all these applications, at the forefront 
2 
 
of this research are hydrogel- based drug delivery devices. Synthetic hydrogels provide an 
effective and controlled way in which to administer protein and peptide based drugs for 
treatment of a number of diseases. A successful drug delivery device relies not only on 
competent network design, but also on accurate mathematical modeling of drug release profiles. 
Hydrogels have ordered polymer networks, with well-defined chemistries yielding well-defined 
physicochemical properties and easily reproducible drug release profiles [1.16].  In order to 
accurately understand and model drug release profiles from a material, it becomes essential to 
have a quantitative mathematical understanding of material properties, interaction parameters, 
kinetics, and transport phenomena within the material in question. The network structure also 
plays a key role in diffusional behavior, mesh size and stability of incorporated drug. It is this 
well-defined order that enables accurate network design by identifying key parameters and 
mechanisms that govern the rate and extent of drug release.  Hydrogels have thus become a 
premier material used for drug delivery formulations and biomedical implants, due to its 
biocompatibility, network structure, and molecular stability of the incorporated bioactive agent. 
1.2 Properties of Hydrogels 
Hydrogels are water swollen polymer matrices, with a tendency to imbibe water when 
placed in aqueous environment. This ability to swell, under biological conditions, makes it an 
ideal material for use in drug delivery and immobilization of proteins, peptides, and other 
biological compounds.  Due to their high water content, these gels resemble natural living tissue 
more than any other type of synthetic biomaterial [1.15]. These networks, have a three 
dimensional structure, crosslinked together either physically (entanglements, crystallites), or 
chemically (tie-points, junctions). This insoluble crosslinked structure allows immobilization of 
active agents, biomolecules effectively, and allows for its release in well-defined specific 
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manner. Thus the hydrogels‟ biocompatibility and crosslinked structure are responsible for its 
varied applications. 
1.2.1 Mechanical Properties 
For non biodegradable applications, it is essential that the carrier gel matrix maintain 
physical and mechanical integrity. Mechanical stability of the gel is, therefore, an important 
consideration when designing a therapeutic system. For example, drugs and other biomolecules 
must be protected from the harmful environments in the body such as, extreme pH environment 
before it is released at the required site. To this end, the carrier gel must be able to maintain its 
physical integrity and mechanical strength in order to prove an effective biomaterial. The 
strength of the material can be increased by incorporating crosslinking agents, comonomers, and 
increasing degree of crosslinking. There is however an optimum degree of crosslinking , as a 
higher degree of crosslinking also leads to brittleness and less elasticity. Elasticity of the gel is 
important to give flexibility to the crosslinked chains, to facilitate movement of incorporated 
bioactive agent. Thus a compromise between mechanical strength and flexibility is necessary for 
appropriate use of these materials. 
1.2.2 Biocompatible Properties 
It is important for synthetic materials, such as hydrogels, to be biocompatible and non-
toxic in order for it to be a useful biomedical polymer. Most polymers used for biomedical 
application must pass a cytotoxicity and in-vivo toxicity tests. Most toxicity problems associated 
with hydrogels arise due to unreacted monomers, oligomers and initiators that leach out during 
application. Thus an assessment of the potential toxicity of all materials used for fabrication of 
gel is an integral part of determining suitability of the gel for biological applications. To lower 
chances of toxic effects, the use of initiators is being eliminated, with the advent of gamma 
irradiation as polymerization technique. Steps are also taken to eliminate contaminants from 
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hydrogels, by repeated washing and treatment. Also, kinetics of polymerization has been 
studied, so as to achieve higher conversion rates, and avoid unreacted monomers and side 
products. 
1.3 Classification of Hydrogels 
Hydrogels can be classified as neutral or ionic, based on the nature of side groups. In 
neutral hydrogels, the driving force for swelling is due to the water-polymer thermodynamic 
mixing contribution to the overall free energy, along with elastic polymer contribution [1.16]. 
The swelling of ionic hydrogels is also affected by the ionic interactions between charged 
polymers and free ions [1.31]. Ionic hydrogels containing ionic groups, such as carboxylic acid, 
imbibe larger amount of water, because of its increased hydrophilicity. Examples of such gels 
are poly(acrylic acid), and polyamines. Hydrogels are also classified as homopolymers or 
copolymers, based on the method of preparation. Hydrogels can be classified based on the 
physical structure of the network as amorphous, semicrystalline, hydrogen bonded structures, 
supermolecular structures and hydrocolloidal aggregates [1.16]. An important class of hydrogels 
are the stimuli responsive gels [1.21]. These gels show swelling behavior dependent on their 
physical environment. These gels can swell, or deswell in response to changes in pH, 
temperature, ionic strength, and electromagnetic radiation [1.27]. These properties allow for 
usage in a number of applications, such as separation membranes, biosensors, artificial muscles, 
and drug delivery devices [1.15].  
1.4 Preparation Methods of Hydrogels 
Hydrogels are polymeric networks. This implies that crosslinks have to be present in 
order to avoid dissolution of the hydrophilic polymer chain in aqueous solution. Hydrogels are 
most frequently used for controlled release of bioactive agents and for encapsulation of cells and 
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biomolecules. In many of these cases the three dimensional structure of the hydrogels have to 
disintegrate into harmless non toxic products to ensure biocompatibility of the gel.  The nature 
of the degradation products can be tailored by a proper selection of the hydrogel building 
blocks. Keeping this consideration in mind, various chemical and physical crosslinking methods 
are used today for the design of biocompatible hydrogels. Chemically crosslinked gels have 
ionic or covalent bonds between polymer chains. Even though this leads to more mechanical 
stability, some of the crosslinking agents used can be toxic, and give unwanted reactions, thus 
rendering the hydrogel unsuitable for biological use. These adverse effects can be removed with 
the use of physically crosslinked gels. In physically crosslinked gels, dissolution is prevented by 
physical interactions between different polymer chains. Both of these methods are used today 
for preparation of synthetic hydrogels and are discussed in detail. In this paper, the hydrogels 
were crossslinked via free radical polymerization on exposure to UV radiation, without the use 
of a crosslinking agent. 
1.4.1 Chemically Crosslinked Gels 
As stated earlier, chemically crosslinked gels are mechanically quite stable due to the 
ionic and covalent bond which comprises these gels. However the addition of crosslinking agent 
leads to adverse effects if the compound is toxic, which on liberation in the body becomes quite 
harmful. The various methods for chemical crosslinking are as follows: 
 Crosslinking of Polymers 
In this method chemically crosslinked gels are formed by radical polymerization of low 
molecular weight monomers, or branched homopolymers, or copolymers in the presence of 
crosslinking agent. This reaction is mostly carried out in solution for biomedical applications. 
Most hydrophilic polymers have pendant hydroxyl group, thus agents such as aldehydes, maleic 
and oxalic acid, dimethylurea, diisocyanates etc that condense when organic hydroxyl groups 
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are used as crosslinking agents. The solvent used for these reactions is usually water, but 
methanol, ethanol and benzyl alcohol have also been used. These solvents can be used only if 
after formation of network structure, the solvent can be exchanged with water. 
A typical reaction scheme for this type of crosslinking is shown [1.37]: 
XYCHCHPYCHCH kn  )2()22(  
        
                                        X                                         P 
 
                                             lCHCH )2(   
Equation 1.1 Typical reaction scheme for Flory type crosslinked structure. 
 
End-linking and crosslinking reactions may also occur in the absence of cross-linking agents if a 
free radical initiator can be used which forms free radicals in the backbone chain. 
 Copolymerization/Crosslinking Reactions 
Copolymerization reactions are used to produce polymer gels, Many hydrogels are 
produced in this fashion, for example poly (hydroxyalkyl methylacrylates). Initiators used in 
these reactions are radical and anionic initiators. Various initiators are used, such as 
Azobisisobutyronitrile (AIBN), benzoyl peroxide etc. Solvents can be added during the reaction 
to decrease the viscosity of the solution. 
o Kinetic Mechanism 
The whole crosslinking mechanism consists of four steps: initiation, propagation, crosslinking, 
and termination. Termination can occur by combination, disproportionation, and chain transfer 




 2𝐴 (1.1)  
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 𝐴 + 𝑀1
𝑘𝑖1
 𝑃1,0,0 (1.2)  
Propagation and cross-linking    𝑃𝑝 ,𝑞 ,𝑟 + 𝑀1
𝑘𝑝11
   𝑃𝑝+1.𝑞 .𝑟   (3) 
 𝑃𝑝 ,𝑞 ,𝑟 + 𝑃𝑥 ,,𝑦 ,𝑧
𝑘𝑝12
   𝑄𝑝 ,𝑞 ,𝑟+1 + 𝑃𝑥 ,𝑦−1,𝑧+1  (1.3) 
Termination by combination 
 𝑃𝑝 ,𝑞 ,𝑟 + 𝑃𝑥 ,,𝑦 ,𝑧
𝑘𝑡𝑐 11
    𝑀𝑝+𝑥 ,𝑞+𝑦 ,𝑟+𝑧   (1.4) 
Termination by disproportionation 
 𝑃𝑝 ,𝑞 ,𝑟 + 𝑃𝑥 ,,𝑦 ,𝑧
𝑘𝑑111
    𝑀𝑝 ,𝑞 ,𝑟 + 𝑀𝑥 ,𝑦 ,𝑧   (1.5) 
Chain Transfer to monomer 
 𝑃𝑝 ,𝑞 ,𝑟 + 𝑀1
𝑘𝑓11
   𝑀𝑝 ,𝑞 ,𝑟 + 𝑃1,0,0  (1.6) 
 𝑃𝑝 ,𝑞 ,𝑟 + 𝑃𝑥 ,,𝑦 ,𝑧
𝑘𝑓12
   𝑀𝑝 ,𝑞 ,𝑟 + 𝑃𝑥 ,𝑦−1,𝑧+1 + 𝑄0,0,1  (1.7) 
HEMA as the monomethacryl monomer and EGDMA as the dimethylacryl monomer, I is the 
initiator, and A is a molecule with initiated radical. Here  𝑃𝑝 ,𝑞 ,𝑟  and 𝑄𝑝 ,𝑞 ,𝑟  represent living 
polymer chains with monomethyacyl and dimethylacryl monomer terminal groups, respectively 
and 𝑀𝑝 ,𝑞 ,𝑟  us dead polymer chain. The subscripts p, q, r are used to describe primary chain; they 
refer to monomethyacryl units, pendant methacryl groups, and cross-links per chain 
respectively. 
 Crosslinking by High Energy Radiation 
High energy radiation, such as gamma [1.38] and electron beam radiation can be used to 
polymerize unsaturated compounds. Water soluble polymers derivatized with vinyl groups can 
be converted into hydrogels using high energy radiation. For example, PEG derivatized to 
PEGDA can form hydrogels once irradiated with UV radiations. Polymers without additional 
vinyl groups can also be crosslinked via radiation. On exposure to gamma or electron beam 
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radiation, aqueous solutions of polymers form radicals on the polymer chains (e.g by the 
hemolytic scission of C-H bonds). Also the radiolysis of water molecules generates the 
formation of hydroxyl groups which can attack polymer chains also resulting in the formation of 
microradicals. Recombination of these microradicals on different chains results in the formation 
of covalent bonds and finally in a crosslinked structure. The swelling and permeability 
characteristics of the gel depend on the extent of polymerization, a function of polymer and 
radiation dose (in general crosslinking density increases with increasing radiation dose). The 
advantage of using this process for gel formation is that in can be done in water under mild 
conditions without the use of a crosslinking agent. However there are some drawbacks to using 
this method, the bioactive material has to be loaded after gel formation, as irradiation might 
damage the agent. Also in some gels like PEG and PVA, the crosslinks consist of C-C bonds, 
which are not biodegradable. 
 Crosslinking Using Enzymes 
Recently a new method was published [1.5] using an enzyme to synthesize PEG-based 
hydrogels. A tetrahydroxy PEG was functionalized with addition of glutaminyl groups and 
networks were formed by addition of transglutaminase into solution of PEG and poly (lysine-co-
phenylalanine). This enzyme catalyzed reaction between γ-carboxamide group of PEG and the 
ε- amine group of lysine to obtain an amide linkage between polymers. The gel properties can 
be tailored by changing ratios of PEG and lysine. 
1.4.2 Physically Crosslinked Gels 
Chemically crosslinked gels imply use of a crosslinking agent, which is often toxic. This 
requires that the crosslinking agent be removed from gel, which can affect the gel integrity. For 
these reasons, physically crosslinked gels are now coming into prominence. Several methods 
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have been investigated exploring preparation of physically crosslinked gels. Below are 
mentioned some of the most widely used methods and their areas of application. 
 Crosslinking by Ionic Interactions 
An example of crosslinking via ionic interactions is crosslinking of Alginate. Alginate 
consists of glucuronic acid residues and mannuronic residues and can be crosslinked by calcium 
ions. Crosslinking can be carried out at normal temperature and pH. These gels are used as 
matrix for encapsulation of cells and for release of proteins. Also Chitosan based hydrogels, as 
well as dextran based hydrogels, crosslinked with potassium ions are also other gels synthesized 
with ionic interactions. In addition to anionic polymers being crosslinked with metallic ions, 
hydrogels can also be obtained by complexation of polyanions and polycations. 
 Crosslinking by Crystallization 
An aqueous solution of PVA that undergoes a freeze-thaw process yields a strong highly 
elastic gel. Gel formation is attributed to the formation of PVA crystallites which act as physical 
crosslinking sites in the network. The gel properties could be modified by varying polymer 
concentration, temperature, and freezing and thawing cycle times. These gels have been shown 
to be useful for drug release [1.9]. 
 Crosslinking by Hydrogen Bonds 
Poly(acrylic acid) and poly(methacrylic acid) form complexes with poly(ethylene 
glycol) by hydrogen bonding between the  oxygen of the poly(ethylene glycol) and the 
carboxylic acid group of poly((meth)acrylic acid) [1.3]. Also hydrogen bonding has been 
observed in poly (methacrylic acid-g-ethylene glycol). The hydrogen bonds are only formed 
when the carboxylic acid groups are protonated. This also implies that the swelling of gels is pH 
dependent. Recently a hydrogel system was developed using the principle of DNA hybridization 
via hydrogen bonding [1.11]. In this approach, oligodeoxyribonucleotides were coupled to a 
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water soluble polymer. Hydrogels were prepared by addition of a complementary 
oligodinucleotide (ODN) either conjugated to the same water soluble polymer or, in its free 
form, to an aqueous solution of the ODN derivatized water soluble copolymer.  
 By Protein Interaction 
Genetic Engineering has also been used for the preparation of hydrogels. The major 
advantage is that the sequence of peptides and, therefore its physical and chemical properties 
can be precisely controlled by the proper design of the genetic code in synthetic DNA sequences 
[1.12]. Cappello and colleagues prepared sequential block copolymers containing a repetition of 
silk-like and elastine –like blocks, in which the insoluble silk like segments are associated in the 
form of aligned hydrogen bonded beta strands or sheets. These hydrogels can also be used for 
drug delivery with drug release influenced by concentration, polymer composition, and 
temperature. Crosslinking by antigen-antibody interaction was also performed [1.13], in which 
an antigen (rabbit IgG) was grafted to chemically crosslinked polyarylaide in the presence of an 
additional crosslinker. Additionally hydrogels have been prepared by immobilizing both the 
antigen and the antibody in the form of an interpenetrating network polymer network. This 
approach might permit drug delivery in response to specific antigen. 
1.5 Monomers Used for Fabrication of Hydrogels 
The monomers used for fabrication of these biocompatible hydrogels have expanded 
from a handful of choices, to several novel materials with tailor-made properties suited to 
particular applications. The first synthesis of hydrogel was that of Wichterle and Lin [1.17] 
using PHEMA (poly (hydroxyethyl methacrylate)) as the monomer. Depending upon the 
application, hydrogel monomers are chosen according to their properties, ease of delivery or 
encapsulations, as well as cost and availability. One of the most traditional monomers used for 
drug delivery of proteins is biodegradable PLGA (polymers of lactic and glycolic acid). 
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However these hydrophobic materials have a tendency to denature protein as well as cause 
inflammation due to degradation. These problems were overcome when researchers turned 
towards hydrophilic monomers. Monomers such as acrylic acid, polyethylene glycol, and 
methacrylic acid are all materials used in therapeutic applications. Researchers are today trying 
to custom-make materials to suit specific applications. PNIPAAm (poly (N-
isopropylacrylamide), PVA (polyvinyl alcohol) are all synthesized by new preparation 
techniques, for distinct applications. Table1.1 provides a list of popular monomers used for 
biomaterial synthesis. 
Table 1.1 Monomers used in synthesis of hydrogels for pharmaceutical applications. From 
Table 1 in ref [1.16] 
 
1.6 PEG (polyethylene glycol) as Suitable Material  
It is known that hydrophilic monomers provide a distinct advantage in both fabrication 
and application of hydrogels. The premier material used today for both drug delivery, cell 
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encapsulation and as adhesion promoters is Poly (ethylene glycol) hydrogels.  PEG has many 
unique properties which make it an ideal choice.  PEG  and its “stealth “ properties , that is once 
its attached to certain formulations, it allows slow release of the formulation, thus enabling 
controlled release, as well as reduce uptake of harmful immunoglobins. This allows longer 
dosage and reduces immunogenicity of substances such as adenosine deaminase (ADA) and 
asparaginase [1.22]. PEG is non toxic, thus ideal for biological applications, and can be injected 
into the body without adverse effects. It is also an FDA approved materials for use in humans. 
PEGylation is an important technique being developed for drug delivery, involves attachment of 
PEG to proteins and drugs, and has great potential for improving pharmokinetic and 
pharmodynamic properties of delivered drugs. Thus PEG has varied uses in the medical field, 
including drug delivery (e.g.; treatment of hepatitis C), laxatives, cell immobilization, (as 
adhesion promoters), biosensor materials, and encapsulation of islets of langerhans for treatment 
of diabetes. It is also used as carrier material for encapsulated cells for tissue engineering 
purposes. Thus PEG, with its biocompatibility, flexibility and stealth properties is an ideal 
material for use in pharmaceutical applications. 
1.7 Applications of Hydrogels 
Water- swollen crosslinked hydrogels have varied applications in fields such as food 
additives [1.10], pharmaceutical [1.16] as well as biomedicine [1.14]. The pioneering work on 
crosslinked HEMA hydrogels was done by Wichterle and Lim in 1954[1.17]. From their 
research, and discovery of the hydrophilic and biocompatible properties of hydrogels, there 
emerged a new class of hydrogel technologies based on biomaterial application. Lim and Sun 
[1.18] in 1980 demonstrated the successful use of calcium alginate microcapsules for cell 
encapsulation. Later natural polymers such as collagen, and shark cartilage were incorporated 
into hydrogels as wound dressings. Natural and synthetic polymers are used for encapsulation of 
13 
 
cells, as well as encapsulation of islets in a semipermeable membrane [1.19]. Hydrogels have 
been used to prevent adhesions and prevent thrombosis after surgery [1.21], and as cell adhesion 
resistant surfaces [1.13]. Microfabricated hydrogel arrays are also used for biosensing[1.25]. 
Hydrogels now play an important role in tissue engineering scaffolds, biosensor and BioMEMS 
devices and drug carriers.  
Among these applications, hydrogel-based drug delivery devices have become a major 
area of study, and several commercially available products are already in the market [1.36].  
Proteins, peptides, DNA based drugs can all be delivered via hydrogel carrier devices. The 
various properties of hydrogels such as biocompatibility, hydrophilicity, flexibility all make it 
ideal for use as drug delivery matrix. 
Hydrogels show good compatibility with blood and other body fluids, thus are used as 
materials for contact lenses, burn wound dressings, membranes, and as coating applied to living 
surfaces. Natural and synthetic polymers have applications as wound dressings [1.32], 
encapsulation of cells [1.26], and recently are being used in the new field of tissue engineering 
as matrices for repairing and regenerating a wide variety of tissues and organs [1.23]. When 
parts, or whole tissues, organs fail, treatments include repair, replacement with a natural or 
synthetic substitute, or regeneration. Implants have been reasonably successful; however tissue 
engineering holds great promise for regeneration. Hydrogels are now being considered as ideal 
matrices for tissue engineering [1.23]. 
1.7.1 Drug Delivery 
Treatment of diseases has always been a major issue for researchers for as long as 
mankind has existed. As technology has advanced, proteins, peptides, and other materials have 
been identified as “drugs” which can be used to treat physiological life processes, pain, and 
discomfort. Drugs can vary in their characteristics to the extent that drugs used to treat the same 
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symptoms might differ in characteristics such as hydrophilicity, chemical composition, size and 
effectiveness. An increasing understanding of cellular biology at the molecular level and 
breakthroughs in proteomics have led to the concept of gene delivery. Drugs have to reach the 
site of action following administration (oral intravenous, transdermal etc) in a specific manner 
and in specific quantity. This is the basis of the drug delivery field. Drug delivery aims at 
delivering the right drug at the right place, at right concentration for the right period of time. 
Sometimes direct delivery of such drugs is difficult, due to the treacherous route of delivery or 
discomfort caused to the patient. For such cases, strategies have been developed for delivering 
drug with a carrier. The drug carrier, whether it be an implantable device, or long chain polymer 
must be biocompatible with the drug and the body. Drug delivery systems alter the 
biodistribution and pharmokinetics of the drug. Therefore one must take into account obstacles 
such as drug solubility, enzyme degradation, toxicity, inability to cross biological barriers as 
well as adverse environmental conditions. In order to make the delivery of the drug effective 
without causing an immune response in the body, proper design and engineering of the drug 
delivery system is essential.  
1.7.2 Hydrogels in Drug Delivery 
Localized drug delivery can be achieved by introducing the drug directly at the target 
site. The major class of biomaterials considered as implantable drug delivery systems are 
hydrogels. These hydrophilic networks are capable of absorbing great amounts of water while 
maintaining structural integrity [1.37]. Their structural similarity to the extracellular matrix 
makes it biocompatible. These synthetic polymers have generated wide interests and are now at 
the forefront of drug delivery research. 
In order to incorporate a preformed gel into the body, an opening must be created, with 
at least the same dimension as that of the gel. This leads to potential risk and discomfort to the 
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patient. Thus focus has shifted to developing injectable materials with ability to form three 
dimensional matrices under physiological matrices. This in situ formation can be achieved 
through specific chemical crosslinking reactions. Gel structuring is triggered by environmental 
stimuli (pH, temperature, solvent exchange etc). Synthetic hydrogels, with their ability to 
imbibe water, flexibility, and biocompatibility, are ideal carriers for the development for novel 
pharmaceutical formulations and for the delivery of drugs, proteins, and as targeting agents for 
drug delivery. The network structure and the nature of components play a key role in the 
diffusional behavior, molecular mesh size changes, and stability of the incorporated bioactive 
agent. The use of hydrogels allows not only delivery of drugs, but also controlled release, in the 
manner required by the pharmaceutical scientists. For example, drugs can be delivered only 
when needed, may be directed to specific site, and can be delivered at specific rates required by 
the body. In the last 20 years, advanced drug delivery formulations have been examined in great 
detail. Reviews related to the various applications of hydrogels in drug delivery and various 
sites available in the body for such are readily available [1.7, 1.2,1.1]. 
1.7.3 Properties Useful in Drug Delivery 
Hydrogels possess several properties that make them an ideal material for drug delivery.  
First, hydrogels can be tailored to respond to a number of stimuli [1.15].  This enables sustained 
drug delivery corresponding to external stimuli such as pH or temperature. These pH sensitive 
gels are useful in oral drug delivery as they can protect proteins in the digestive track. pH 
responsiveness is also useful for lysosomal escape during gene delivery. Second, Hydrogels can 
also be synthesized to exhibit bioadhesiveness to facilitate drug targeting, especially through 
mucus membranes, for non-invasive drug administration [1.30]. Finally, Hydrogels also have a 
“stealth” characteristic in vivo circulation time of delivery device by evading the host immune 
response and decreasing phagocytic activity [1.20].  
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1.7.4 Applications of Hydrogels in Drug Delivery 
Advances in recombinant protein technology have identified several protein and peptide 
therapeutics for disease treatment. However, the problem which plagued researchers was how to 
effectively deliver these biomolecules. Due to their large molecular weight, and three 
dimensional structure, the most commonly used route for drug administration is by intravenous 
or subcutaneous injection. Unfortunately proteins and peptides are prone to proteolytic 
degradation, thus they experience short plasma circulation times and rapid renal clearance, 
leading to multiple daily injections or increased dosage in order to maintain the required drug 
therapeutic levels . Multiple injections are difficult for the patient, while high doses might be 
toxic, and induce serious immune response. Hydrophobic polymeric controlled release 
formulations, such as PLGA, offer a sustained release mechanism in which drug release rates 
can manipulated by changing polymer molecular weight and composition. These polymers 
however induce adverse effects to the encapsulated proteins or peptides during network 
preparation and delivery [1.16], as well as trigger the immune response. Hydrophilic hydrogels, 
on the other hand, provide relatively mild network fabrication technique and drug encapsulation 
conditions, making them the ideal material for use in drug delivery. Thus hydrogels are 
primarily used for encapsulation of bioactive materials and their subsequent controlled release. 
If designed properly, hydrogels can be used in a variety of applications such as sustained, 
targeted, or stealth biomolecule delivery. Hydrogel based delivery devices can be used for oral, 
ocular, epidermal and subcutaneous application. The Fig 1.1 below indicates various sites that 
are available for the application of hydrogels for drug delivery. These applications are discussed 
in detail below. 
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 Drug Delivery in the GI Tract 
The ease of administration of drugs, and the large surface area for absorption makes the 
GI tract most popular route for drug delivery. It is however, also a very complex route, so that 
versatile approaches are needed to deliver drugs for effective therapy. Hydrogel-based devices 
can be designed to deliver drugs locally to specific sites in the GI tract. 
 
Figure 1.1 Tissue locations applicable for hydrogel based drug delivery systems. From 
Figure 2 in ref [1.16] 
 
For example, Patel and Amiji [1.35] proposed stomach –specific antibiotic drug delivery 
systems for the treatment of Helicobacter pylori infection in peptic ulcer disease. They 
developed cationic hydrogels with pH sensitive swelling and drug release properties for 
antibiotic delivery in the acidic environment of the stomach.  There are still many drawbacks for 
peroral delivery of peptides and proteins to GI tract, like protein inactivation by digestive 
enzymes in the GI tract and poor epithelial permeability of the drugs. However certain 
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hydrogels may overcome some of these problems by appropriate molecular design or 
formulation. For example Akiyama [1.26] reported novel peroral dosage forms of hydrogel 
formulations with protease inhibitory activities.  
Recently oral insulin delivery using pH responsive complexation hydrogels was reported 
[1.37]. The hydrogels used were crosslinked copolymers of PMMA with graft chains of 
polyethylene glycol. These hydrogels protect the insulin in the harsh, acidic environment of the 
stomach before releasing the drug in the small intestine. 
The colonic region has also been considered as a possible absorption site for orally 
administered proteins and peptides, mostly due to a lower proteolytic activity in comparison to 
that in the small intestine. Several hydrogels are currently being investigated as potential 
devices for colon-specific drug delivery. These include chemically or physically crosslinked   
polysaccharides such as dextran [1.8], guar gum 1.28] and insulin [1.18]. They are designed to 
be highly swollen or degraded in the presence of colonic enzymes or microflora, providing 
colon-specificity in drug delivery. 
 Rectal Delivery 
This route has been used to deliver many types of drugs for treatment of diseases 
associated with the rectum, such as hemorrhoids.  This route is an ideal way to administer drugs 
suffering heavy first-pass metabolism. There are however, some drawbacks associated with 
rectal delivery. For example, due to discomfort arising from given dosage forms, there is 
substantial variability in patient‟s acceptance of treatment. Also, if drugs diffusing out of the 
suppositories are delivered in an uncontrolled manner, they are unable to be retained at a 
specific position in the rectum, and tend to migrate upwards to the colon. This leads to variation 
of availability of drugs, especially those that undergo extensive first-pass elimination. 
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Hydrogels offer a way in which to overcome these limitations, provided that the 
hydrogels show bioadhesive properties. It was reported [1.19] that increased bioavailability of 
propanol subject to extensive first-pass metabolism was observed by adding certain 
mucoadhesive polymeric compounds to poloxamer –based thermally gelling suppositories. The 
polymeric compounds tested were polycarbophil and sodium alginate. Miyazaki et al. [1.34] 
investigated the potential application of xyloglucan gels with a thermal gelling property as 
matrices for drug delivery. Another important issue in rectal drug delivery is to avoid rectal 
irritation. The products discussed above, indicated no such mucosal irritation after drug 
administration. 
 Ocular Delivery 
Drug delivery to the eye is difficult due to its protective mechanisms, such as effective 
tear drainage, blinking, and low permeability of the cornea. Thus, eye drops containing drug 
solution tends to be eliminated rapidly from the eye and the drugs show limited absorption, 
leading to poor ophthalmic bioavailability. Due to the short retention time, a frequent dosing 
regimen is necessary for required therapeutic efficacy. These challenges have motivated 
researchers to develop drug delivery systems that provide prolonged residence time. 
The earlier dosage forms, such as suspension and ointments could be retained in the eye, 
but sometimes gave patients an unpleasant feeling because of the nature of solids and semi-
solids. Hydrogels, because of their elastic properties can represent an ocular drainage-resistant 
device. In-situ forming hydrogels are attractive as an ocular drug delivery system because of 
their facility in dosing as a liquid, and long term retention property as a gel after dosing. 
Cohen et al [1.26] developed an in-situ gelling system of alginate with high gluronic acid 
contents for the ophthalmic delivery of pilocarpine. This system extended the duration of the 
pilocarpine to 10 hr, compared to 3 hr when pilocarpine nitrate was dosed as a solution. Chetoni 
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et al.[1.34] reported silicone rubber hydrogel composite ophthalmic inserts. An in-vivo study 
using rabbits showed a prolonged release of oxytetracycline from the inserts for several days. 
 Transdermal Delivery 
Drug delivery to the skin has been generally used to treat skin diseases or for 
disinfection of the skin. In recent years, however a transdermal route for the delivery of drugs 
has been investigated. Swollen hydrogels can be delivered for long duration and can be easily 
removed. These hydrogels can also bypass hepatic first-class metabolism, and are more 
comfortable for the patient. Hydrogel based delivery devices have been proposed by Sun et al. 
[1.4], such as composite membranes of crosslinked PHEMA with a woven polyester support. 
Also hydrogels have been reported [1.11] which have been obtained by the copolymerization of 
bovine serum albumin (BSA) and PEG. These hydrogels can be used as controlled release 
devices in the field of wound dressing. Hubbell [1.12] has also carried out extensive research on 
in-situ photopolymerization made from terminally diacrylated ABA block copolymers of lactic 
acid oligomers (A) and PEG (B) for barriers and local drug delivery in the control of wound 
healing. 
Current research in this field is now focused on electrically-assisted delivery using 
iontophoresis and electroporation [1.35]. Hydrogel-based formulations are being looked at for 
transdermal iontophoresis to obtain enhanced permeation of products in question such as, 
hormones [1.35] and nicotine. 
 Subcutaneous Delivery 
Among the varied possible pharmaceutical applications of hydrogels, the most 
substantial application is probably in implantable therapeutics. Implantable devices that are 
subcutaneously inserted tend to illicit immune response of the body, leading to inflammation, 
carcinogenicity and immunogenicity. Thus biocompatibility becomes a major issue, and all 
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implantable materials must be compatible with the body. Hydrogels are an ideal candidate for 
implantable materials. They have high water content, environment similar to biological tissue, 
making them relatively biocompatible. They also have other properties which make them a 
viable choice [1.1]; (1) minimal mechanical irritation upon in-vivo implantation due to their 
soft, elastic properties (2) prevention of protein absorption and cell adhesion arising from the 
low interfacial tension between water and hydrogels (3) broad acceptability for individual drugs 
with different hydrophilicities and molecular sizes, and (4) can manipulate crosslinking density 
and swelling for release of incorporated drug in specific manner. Thus hydrogels are an ideal 
material to be used for delivery of proteins and peptides. 
Hydrogel formulations for subcutaneous delivery of anticancer drugs have been 
proposed. For example, crosslinked PHEMA was applied to cyratabine (Ara-C) [1.6]. Current 
studies on implantable hydrogels are leading towards the development of biodegradable 
systems, which don‟t require surgical removal once the drug has been administered. 
Biodegradable PEG hydrogels are now at the forefront of this research, and several novel 
systems have been developed. One type is synthesized via a polycondensation reaction between 
functional PEG acids and branched PEG polyols. Another type is PEG based hydrogels having 
functional groups in which the protein drugs can be covalently attached to the gel network via 
ester linkages. In this case, the release of the immobilized proteins would be controlled by the 
hydrolysis of ester linkage between the gel and protein, followed by diffusion of protein, and 
degradation of gel. 
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Chapter 2 : Network Structure 
2.1 Introduction  
The properties of the hydrogel which make it favorable for use in various pharmaceutical 
as well as medicinal purposes arise mostly from its crosslinked structure. The crosslinked 
structure of the gel is determined by the nature of monomers, method of preparation, and nature 
of crosslinking agent. To understand the crosslinked structure of the gel, the most common 
approach used is the study of gel swelling. The swelling of the gel is studied and certain 
parameters of swelling are calculated. Knowledge of the swelling characteristics of the gel is the 
first step in understanding the network structure of the gel and its capacity to function as a drug 
delivery carrier. Several theories have been proposed to explain the network structure of the gel, 
as well as the mechanism of swelling of gel. Some theories take into account the real network 
structure with defects, while others consider ideal network structure, due to its simplicity in 
analysis.  In each of these cases, the hydrogel is exposed to a penetrant solvent and allowed to 
swell until equilibrium is reached. Once the hydrogel is exposed to solvent, the gel swells, and 
the thermodynamically driven swelling force is counterbalanced by the retractive force of the 
crosslinked structure, leading to an equilibrium state. This swollen state allows widening of the 
gap between the crosslinks and mesh size, thus facilitating the transfer of different solutes 
through the gel. The transfer of the solute is controlled by the swelling of the gel. Once this 
information is known, the gel can be manipulated by varying mesh size, and property of drug to 
enable diffusion of required drug in specific manner. 
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2.2 Cross Linked Structure 
Hydrogels are actually cross linked three dimensional matrices, which can be formed by 
covalent, ionic, and, in some cases, by Van der waals and hydrogen bonds [2.12]. The network 
structure of the hydrogel depends on its constituent monomers, the method of preparation and 
method of crosslinking. Most hydrogels used for biomedical applications are noncrystalline. 
These networks contain localized ordered structures or nonhomogenous structures, unlike the 
common Flory [2.3] picture of a randomly crosslinked mass of molecular chains.  
Characterization of the hydrogel network structure is quite complicated because of the many 
types of possible networks, including regular, irregular, loosely crosslinked, highly crosslinked 
and imperfect networks. For the purposes of characterizing the network structure for medical 
applications, an ideal network of chains is usually assumed.  An ideal network that is, a 
Gaussian network is usually assumed, with a collection of Gaussian chains between 
multifunctional junction points (crosslinks). This Gaussian model has two significant 
assumptions [2.12]. 
 crosslinked polymer chains are represented by a Gaussian distribution . This implies 
that the end to end distance is much smaller than the contour length of the chain.  
 Crosslinks, on an average are tetra functional. 
2.2.1 Real Networks and Network Defects 
Real polymer networks always deviate from the ideal Gaussian model. Imperfections 
can arise for a number of reasons. There might be deviations from the original conditions of 
crosslinking, crosslinking of already crosslinked networks and end-linking. 




Figure 2.1 Ideal Gaussian network Mc is the molecular weight betweeen crosslinks. From 
Fig 3 in ref[2.12] 
 
 Pre-Existing Order 
These types of imperfections include crystallites showing three dimensional structure, 
non-randomly oriented segment sequences, artificially oriented chains, and micellar and 
globular structures.  These are probably caused due to the association of dissimilar parts of the 
chain. 
 Network Defects 
These include closed loops, unreacted functionalities, and chain entanglements [Fig 2] 
 Inhomogeneities 
 Phase Separation Structures 
 Phase separation occurs when the critical value of crosslinking density is exceeded, because the 
amount of solvent in the gel has exceeded maximum swelling capacity. 
2.3 Swelling Parameters and Their Significance 
As mentioned earlier, for biomedical purposes, the hydrogel network is considered to be ideal. 




Figure 2.2 Network Defects (A) Loops (B) Entanglements (C) Unreacted Functionality. 
From  Fig 4 in ref[2.12] 
 
the gel network are determined. The most important parameters  used to characterize network 
structure are the polymer volume fraction in the swollen state (𝜈2,𝑠), molecular weight of the 
polymer chain between two neighboring cross links (Mc) ,and the corresponding mesh size (ξ) 
[2.8]. Due to the random nature of the polymerization process, only average values of Mc can be 
calculated. The polymer volume fraction in the swollen state is a measure of the amount of fluid 
absorbed and retained by the gel.  Mc is a measure of the degree of crosslinking of the polymer, 
regardless of the nature (physical or chemical) crosslinking. The mesh size, or the correlation 
distance between two adjacent crosslinks, provides a measure of the space available between the 
macromolecular chains available for diffusion and movement of particles. This is also an 
average value. These three parameters can be determined using the equilibrium swelling theory 
[2.3]. The three parameters are critical in describing the nanostructure of the crosslinked 
hydrogels. 
 Polymer Volume Fraction 
The polymer volume fraction is described as the ratio of the polymer volume (𝑉𝑝) to the swollen 




















 (2.1)       
 Molecular Weight Between Crosslinks 
The average molecular weight between crosslinks𝑀 𝑐 , in gels crosslinked during polymerization 



















Here 𝑀 𝑛  is the average molecular weight of the linear polymer chains, 𝜈 is the specific volume 
of polymer, 𝑉1 is the molar volume of water, and 𝜒1 is the polymer-water interaction parameter. 
 Mesh Size 
Mesh size can be described using the following equation [2.8]: 
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2   (2.3) 
 𝑟0
2    
1/2
 is the root mean squared end to end distance of network chains between two adjacent 
crosslinks in the unperturbed state.  
Once the nanostructure of the gel is known, a clear idea is obtained about its suitability 
for use in drug delivery.  The amount of liquid retained, the distance between polymer chains, 
and flexibility of those chains together determine the mobility of the encapsulated molecule and 
their rates of diffusion within the matrix. 
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2.4 Significance of Mesh Size 
For drug delivery formulations with matrix carrier, it is essential to understand the 
mechanism by which solute mass transfer takes place from the gel matrix to the specific site 
[2.2]. For non-biodegradable gels, diffusion is the main mechanism of transport of the solute, 
and in the case of hydrogels, this mass transfer is achieved by the swelling of the gel.  To 
understand the mass transfer in the gel, one must study its water-sorption characteristics, thus 
obtaining a clear view of the morphological structure of the gel.  Once the crosslinked gel is 
exposed to solvent, it absorbs the solvent and swells until it reaches its equilibrium swelling 
state. As the gel swells, the cross linked chains widen, thus increasing the mesh size and 
allowing solute transfer to take place from the gel. This degree of swelling is directly related to 
the amount of solute transfer, as shown below [2.5]: 
 
Figure 2.3 Schematic of mesh size in hydrogels at (A) deswollen state (B) swollen state. ξ is 








Figure 2.4 Schematic of solute mass transfer in gel (1) solute traversing through network 
(2)crosslinked network (3) solvent surrounding gel. From Fig 1 in ref [2.13] 
 
Once the gel has imbibed liquid, the mesh size widens, allowing free passage of the 
solute in question.  From the swelling experiments, mesh size of the gel can be determined. 
Once the mesh size has been calculated, it can be compared to the hydrodynamic diameter of 
solute molecules to determine whether diffusion of solute is possible. Theoretically no solute 
diffusion is possible within the matrix when the mesh size is close to the size of the solute [2.5]. 
Mesh size is affected by many factors [2.5]: 
 Degree of crosslinking of the gel 
 Stimuli such as temperature, pH and ionic strength 
 Chemical structure of the constituting monomers 
Mesh size is an important factor for determining mechanical strength, degradability, and 
diffusivity of the releasing molecule [2.9, 2.10, 2.1]. Most hydrogels used in biomedical 
applications have mesh sizes ranging from 5 to100nm [2.7], in their swollen state. These size 
scales are much larger than most small molecular weight drugs used in pharmaceutical 
formulations, and, therefore, diffusion of these drugs in swollen matrices is not hindered. 
However large macromolecules, such as large molecular weight proteins, peptides, and 
oligonucleotides may be retarded in the swollen gel due to their large hydrodynamic radii in 
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comparison to the gel mesh size.  If designed effectively, the structure and mesh size of the gel 
can be manipulated in order to obtain desired rates of macromolecule diffusion. 
2.5 Swelling Theories 
As mentioned earlier, there are different theoretical models used to determine the 
crosslinking density of a hydrogel. The two most commonly used theories to this end are the 
equilibrium swelling theory and the rubber elasticity theory [2.8].  
2.5.1 Equilibrium Swelling Theory 
This is the most well known model used to calculate the number average molecular 
weight between crosslinks. It is also known as the Gaussian model (Flory-Rehner). The model is 
based on two assumptions: 
 The crosslinked polymer chains can be represented by a Gaussian distribution. 
 The crosslinks on the average are tetrafunctional  
If an uncrossed polymer is soluble in a certain solvent, then that same polymer, when 
crosslinked will swell on exposure to that solvent [2.7].  As the matrix is swollen by the liquid, 
the chains between the cross-links become elongated so that a force opposite to the elastic 
retractive force of the chain develops. On further swelling of the polymer matrix, the force 
increases whereas the thermodynamic force of dilution decreases.  This theory states that these 
forces come to equilibrium that is the thermodynamic force of mixing and the retractive force of 
the polymer chain. 
 ∆𝐺𝑡𝑜𝑡𝑎𝑙 = ∆𝐺𝑒𝑙𝑎𝑠𝑡𝑖𝑐 + ∆𝐺𝑚𝑖𝑥𝑖𝑛𝑔   (2.4) 
Here,  ∆𝐺𝑒𝑙𝑎𝑠𝑡𝑖𝑐  is the contribution due to the elastic forces developed inside the gel, 
and ∆𝐺𝑚𝑖𝑥𝑖𝑛𝑔  is the result of spontaneous mixing of fluid molecules in the polymer chains, and 
is a measure of how compatible the polymer is with the molecules of the surrounding fluid.  
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 ∆𝐺𝑚𝑖𝑥𝑖𝑛𝑔 =𝑘𝑇 𝑛1𝑙𝑛𝑣1 + 𝑛2𝑙𝑛𝑣2 + 𝜒𝑛1𝑣2  (2.5) 
 Where, 
𝑛1 - moles of swelling agent 
𝑛2 -moles of polymer 
𝑣1 –volume fraction of swelling agent 
𝑣2 -volume fraction of polymer 
k- Boltzmann constant 
𝜒 - Flory polymer-solvent interaction parameter 
For a cross-linked system without uncrosslinked polymer chains (𝑛2 = 0) 
                                                                ∆𝐺𝑚𝑖𝑥 = kT [𝑛1𝑙𝑛𝑣1 + 𝜒𝑛1𝑣2] (2.6) 
The deformation process must occur without appreciable change in the internal energy, thus the 
internal energy and, therefore, the elastic free energy is defined by 
 ∆𝐺𝑒𝑙 = −𝑇∆𝑆𝑒𝑙  (2.7)  
Where ∆𝑆𝑒𝑙  is the change in entropy from deformation process. For isotropic swelling, elastic 
free energy is, 




2 − 3 − 𝑙𝑛𝛼𝑠
3)  (2.8) 
𝜈𝑒  - effective number of chains in the network 
𝛼𝑠  - Expansion factor expressing the linear deformation of a network structure due to isotropic 
swelling 



































  (2.10) 
𝑉0 = molecular weight of the network before swelling 
𝑉1 = molar volume of the swelling agent 











Using this relationship between Eq (2.11) and Eq (2.10) and also evaluating the two remaining 





= 𝑅𝑇  ln 1 − 𝜈2, + 𝜈2 + 𝜒𝜈2








    (1) 
𝜈2,𝑠  is defined as the concentration at which activity of the swelling agent one. 
Then at equilibrium state, 
  𝑙𝑛 1 − 𝜈2,𝑠  + 𝜈2,𝑠 + 𝜒𝜈2,𝑠
2  = 𝑉1 𝜈𝑒/𝑉0  𝜈2,𝑠
1/3
− 𝜈2,𝑠/2   (2) 
Now writing above equation (2.13) in terms of the following two equations Eq (2.14) and 
(2.15): 
 𝜈𝑒 = 𝜈  1 − 2
𝑀𝑐
𝑀𝑛     
   
   (2.14) 
And,   𝜈 = 𝑉/    𝜈 𝑀 𝑐  (2.15) 
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And upon rearrangement, one obtains the Flory-Rehner model: 
 
1
𝑀𝑐    
=
2












  (2.16) 
 𝑀 𝑐  - number average molecular weight between crosslinks 
 𝑀 𝑛  - number average molecular weight of polymer before crosslinking 
Peppas and Merrill modified the above original Flory-Rehner model for hydrogels 
prepared in the presence of water. The presence of water modifies the change of chemical 
potential due to elastic forces. There must now be a term which accounts for the volume fraction 
density of the chains during crosslinking. The equation below predicts the molecular weight 























  (2.17) 
𝑣2,𝑟  - polymer volume fraction in the relaxed state( after crosslinking, before swelling)      
2.5.2 Rubber Elasticity Theory 
The other theory used to determine crosslinked structure of a gel is the rubber elasticity 
theory. Hydrogels resemble natural rubbers in their property to elastically respond to applied 
stress. Thus when a crosslinked network is stretched, it reaches an equilibrium strain while the 
stress remains constant. A hydrogel subjected to small deformation, less than 20% [2.5] will 
fully recover to its original dimension rapidly. The rubber elasticity theory [2.7] is used to 
explain this behavior, thermodynamically. This theory was first developed by Treolar [2.11] and 
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Flory [2.7] for vulcanized rubbers and modified to polymers. Later expressions were developed 
which apply to hydrogels prepared in presence of solvent [2.6]. 

















  (2.18) 
Here 𝜏 is the stress applied to the polymer sample, 𝜌 is the density of the polymer, R is the 
universal gas constant, T is the absolute experimental temperature, and 𝑀 𝑐  the average 
molecular weight between crosslinks. 
To be able to analyze the structure of the hydrogel using this theory, experiments need to 
be performed using a tensile system. This theory can be used to analyze chemically, physically 
crosslinked as well as hydrogels exhibiting temporary crosslinks due to hydrogen bonding. 
2.5.3 Calculation of Mesh Size 
The mesh size defines the space between macromolecular chains in a crosslinked 
network, and is characterized by the correlation length, ξ between two adjacent crosslinks. The 
calculations for the mesh size can be conducted as follows using the following equations [2.8]: 




Here 𝛼 is the elongation ratio of the polymer chains in any direction, and  𝑟 0
2 1/2 is the root 
mean square, unperturbed end to end distance of the polymer chains between two neighboring 
crosslinks [2.8]. 
For isotropically swollen hydrogels, 𝛼 is related to the polymer volume fraction 𝜈2,𝑠 as follows: 
 𝛼 =  𝜈2,𝑠  
−
1




2 1/2 can be calculated using the following equation[2.4]: 
  𝑟 0
2 
1
2 = 𝑙 𝐶𝑛𝑁 
1
2 (2.21) 
Where 𝐶𝑛  the Flory characteristic ratio is 𝑙 is the length of the bond along the polymer 





𝑀𝑟  is the molecular weight of the repeating units from which the polymer chain is composed. 
When one combines the above equations Eq (2.20), (2.21), (2.22) and rearranges them, we 
obtain the equation for calculation of the mesh size in a swollen hydrogel: 






2  (2.23) 
Thus calculation of the mesh size and other swelling parameters allow for proper design and 
characterization of diffusion of model drugs and proteins into the complex structure of gels. 
2.6 References 
2.1. Amsden, B., Solute diffusion in hydrogels. An examination of the retardation effect. 
Polymer Gels and Networks, 1998. 6(1): p. 13-43. 
2.2. Favre, E., et al., Diffusion of polyethyleneglycols in calcium alginate hydrogels. Colloids 
and Surfaces A: Physicochemical and Engineering Aspects, 2001. 194(1-3): p. 197-206. 
2.3. Flory, P.J., Molecular theory of rubber elasticity. Polymer, 1979. 20(11): p. 1317-1320. 
2.4. Hickey, A.S. and N.A. Peppas, Mesh size and diffusive characteristics of semicrystalline 
poly(vinyl alcohol) membranes prepared by freezing/thawing techniques. Journal of 
Membrane Science, 1995. 107(3): p. 229-237. 
2.5. Lin, C.-C. and A.T. Metters, Hydrogels in controlled release formulations: Network 




2.6. Nikolaos A. Peppas, E.W.M., Crosslinked poly(vinyl alcohol) hydrogels as swollen 
elastic networks. 1977. p. 1763-1770. 
2.7. Paul J. Flory, N.R.M.C.S., Dependence of elastic properties of vulcanized rubber on the 
degree of cross linking. 1949. p. 225-245. 
2.8. Peppas, N.A., et al., Hydrogels in pharmaceutical formulations. European Journal of 
Pharmaceutics and Biopharmaceutics, 2000. 50(1): p. 27-46. 
2.9. Peppas, N.A., et al., Poly(ethylene glycol)-containing hydrogels in drug delivery. Journal 
of Controlled Release, 1999. 62(1-2): p. 81-87. 
2.10. Tiziana Canal, N.A.P., Correlation between mesh size and equilibrium degree of 
swelling of polymeric networks. 1989. p. 1183-1193. 
2.11. Turner, A., Jr., The physics of rubber elasticity. L. R. G. Treloar, Oxford Univ. Press, 
New York, 1949, 262 pp. 1950. p. 387. 
2.12 N.A. Peppas: Hydrogels in Medicine and Pharmacy, Vol. 1. Fundamentals, CRC Press, 
Boca Raton, FL, 1986, 180 pages. 
2.13     Hoffman, A.S., Hydrogels for biomedical applications. Advanced Drug Delivery 




Chapter 3 :Analysis of Drug Transport 
                Mechanism 
3.1 Introduction 
For a successful drug delivery system, it is imperative that one can predict the 
mechanism of release of the active agent. This is also one of the most challenging fields in drug 
delivery, and over the years researchers have predicted the release of active drugs as a function 
of time, using both simple and sophisticated mathematical models. Mathematical models give us 
an insight into mass transport, as well as the effect of design parameters, such as device 
geometry and drug loading, on the release mechanism of the active agent in question. These 
models are important in both the design stage as well as in the experimental verification of the 
release mechanism [3.21]. Thus accurate data, along with models accurately representing the 
data, together provide a valuable insight into the actual release mechanism. Most of the 
theoretical models found in literature are based on diffusion equations. Diffusion is a 
phenomenon largely dependent on the structure of the gel matrix through which it occurs; thus 
the morphology of the polymeric materials must be taken into account for an accurate model to 
be selected [3.12]. Controlled release systems can be categorized based on the rate limiting step 
and can classified as follows [3.12]: 
 Diffusion-Controlled (drug diffusion from the non-degraded polymer) 
 Swelling-Controlled (enhanced drug diffusion due to polymer swelling) 
 Chemically Controlled (drug release due to polymer degradation and erosion) 
Ordinary diffusion takes place to a certain degree, in each of these mechanisms, thus an 
understanding of the fundamentals of diffusion, and related mathematical relations are an 
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integral part of understanding the release mechanism of any agent through these gel matrices. 
For a non biodegradable matrix, drug release occurs due to the concentration gradient either via 
diffusion or matrix swelling. For biodegradable matrices, release is controlled by the hydrolytic 
cleavage of polymer chains that lead to matrix erosion [3.12]. Thus each system has different 
models which are developed according to the type of release. Simple equations have been 
developed for describing drug release of various polymers of different shapes using the 
principles of diffusion. The diffusion coefficient is defined in several different ways according 
to the nature of pores in the system. It is observed that diffusion can be Fickian, anomalous, or 
Case-II type diffusion. Fickian diffusion and its diffusion coefficient can be easily described 
using equations derived from Fick‟s law and its solutions. Short time approximations of these 
solutions have been shown to be effective only for the first 60% of drug release, when the aspect 
ratios are consistent with those of either a flat disk, or a long cylinder. Three dimensional 
analysis of cylindrical polymers is challenging, thus one dimensional approximate solutions are 
used to understand the diffusion of drug from long cylinders. Though most of the equations 
elucidated in this paper were developed for non-swellable polymers, most also hold true for 
moderately swellable polymers. The mathematics of the diffusion equation does not change, 
only the interpretation of the diffusion coefficient is altered. 
3.2 Diffusion Controlled System 
Diffusion controlled is the most widely used for describing controlled release of drugs. Fick‟s 
law of diffusion with either constant or variable diffusion coefficients is used in modeling this 
controlled release. For diffusion–controlled microspheres, the drug release profile is obtained by 
solving Fick‟s second law of diffusion with appropriate boundary conditions. Fick‟s second law 
[3.3] is solved to obtain various analytical solutions to different boundary conditions. The 
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boundary conditions are determined by mass transfer process at the surface and the volume of 
the surrounding system. 
Given below is a schematic illustration of the cross sections of drug loaded spheres [3.1].  
 
 
Figure 3.1 Schematic illustration of cross section of drug loaded spheres (a) reservoir 
system (b) dissolved drug system (c) dispersed drug system. (Adapted from Fig 1 in 
ref[3.1]) 
 
Based on the matrix region where most of the drug diffusion takes place, the diffusion 
controlled system can be further divided into reservoir and matrix systems [3.1]. The reservoir 
system consists of a drug reservoir surrounded by the polymer matrix shell. In the matrix 
system, the drug is incorporated in the matrix, either in dissolved or dispersed condition. 
3.2.1 Reservoir System 
The reservoir model consists of a bioactive agent containing a core that is separated from 
the external environment by a polymer membrane [3.1]. It assumes that the drug is restrained by 
a spherical shell of outer radius 𝑟𝑒 and inner radius 𝑟𝑖 , thus the drug diffuses through a layer of 
thickness (𝑟𝑒  − 𝑟𝑖 ). 
On solving Fick‟s second law of diffusion, the drug distribution within the shell 
boundary, along with appropriate boundary conditions, gives the rate of release of the drug, and 
the total amount of drug released for systems of spherical geometry [3.12]. 








 𝑟𝑒−𝑟𝑖 / 𝑟𝑒𝑟𝑖 
 𝑐𝑖2 − 𝑐𝑖1   (3.1) 
 𝑀𝑡 =
4𝜋𝐷𝑖𝑝 𝐾 𝑐𝑖2−𝑐𝑖1 
 𝑟𝑒−𝑟𝑖 / 𝑟𝑒𝑟𝑖 
  (3.2) 
Here, 
𝐷𝑖𝑝  - Concentration independent diffusion coefficient 
𝑀𝑡  - Amount of drug released at time t 
K- Drug partition coefficient  
𝑐𝑖2 - Drug concentrations outside 
𝑐𝑖1 - Drug concentration inside 
On developing analogous equations for different geometries such as, planar and 
cylindrical it was concluded that drug release can be controlled by the geometry of the system. 
The drug released can also be influenced by different factors such as thickness of the membrane, 
the concentration gradients across the membrane, and structure of the polymer. 
3.2.2 Matrix System 
This model assumes that the drug is uniformly distributed inside the polymer matrix. 
This model is valid for non biodegradable polymers. In this type of model, there are two sub-
classifications [3.1]: 
 Initial drug loading is lower than the solubility of the drug inside the polymer matrix 
(dissolved drug  system) 






 Dissolved Drug System 
When the surface resistance to mass transfer at the surface is negligible, then fractional amount 













 ∞𝑛=1   (3.3) 
𝑀∞  is the cumulative drug released at infinite time 
On the other hand, if convective mass transfer is dominant, then the fractional amount of drug 














𝐷𝑡   (3.4) 
Sh is the Sherwood number, defined as Sh = hR/D, and the 𝛽𝑛 s are the roots of the 
equation𝛽𝑛𝑐𝑜𝑡𝛽𝑛 = 1 − 𝑆𝑕. Thus the finite mass transfer solution depends on Sh. 
 Dispersed Drug System 
In this model, the polymer matrix can be divided into two regions [3.1]: 
 Core in which undissolved solute exists at concentration 𝐶0 (non diffusing region) 
 Dissolved (diffusing) region, where all solute is dissolved and diffusion occurs. 
This model is not applicable if 𝐶0/𝐶𝑠 is not very large. This separation between the two regions 
is valid when 𝐶0 > 𝐶𝑠 . The core region in this model shrinks as drug diffuses out, thus allowing 
for a moving boundary system. This system is however difficult to solve analytically. A 
schematic illustration of concentration profiles for this type of system is as shown [3.1]  
3.3 Chemically Controlled System 
Based on the mechanisms that control drug release, chemically controlled systems can 




Figure 3.2 Schematic diagram showing concentration profile in sphere of dispersed drug 
system in perfect sink system. From Fig 2 in Ref[3.1] 
 
 Erodible system- drug release rate is controlled by degradation or dissolution of the 
polymer. 
 Pendant chain system- drug is attached to the polymer via a hydrolytically or 
enzymatically labile bond, and drug release is controlled by rate of degradation of bond. 
Bioerodible polymers have now found uses in biomedical applications especially for    
drug delivery systems due to a variety of reasons [3.12]: 
 Chemistry and surfaces can be manipulated to stabilize bioactive agents, and enhance 
tissue for site-targeting 
 Erosion kinetics can be customized by careful selection of polymer and different 
techniques of encapsulation of drug, to control drug release. 
The polymer erosion is mainly described by the terms degradation and erosion. 
Degradation refers to the polymer chain/bond cleavage/scission reaction, whereas erosion 
designates the loss of polymer material in monomers or oligomers. Thus erosion may consist of 
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several physical and chemical steps, including degradation. Erosion controlled systems are quite 
complex, so the physiochemical characteristics of drug devices are an important factor that must 
be known in order to understand the mechanism of drug release. It is necessary to identify the 
dominant mechanism of release, and to this end, transient conditions are imposed on the system 
to obtain a more accurate model. Several techniques have been used to study the release 
properties of polymeric devices [3.11]. Gel permeation chromatography is used to monitor 
molecular weight changes in the polymer during drug release and erosion. The cumulative 
monomer release can be related to cumulative drug release profiles to indicate the relative 
contributions of erosion and degradation on drug release. Differential scanning calorimetry can 
measure the degree of crystallinity and glass temperature (Tg) changes. Tg is important since in 
polymers, systems above the Tg are characterized by a rubbery state and high mobility of 
polymer chains, leading to a free volume for diffusion of drug to occur.  If the system is below 
the Tg, then the polymer is in glassy state and diffusion is difficult. Scanning electron 
Microscopy (SEM) is used to understand the microstructure of the polymer matrix. 
The two possible mechanisms of erosion, heterogeneous and homogenous, can be 
predicted from polymer hydrophobicity and morphology.  Hydrophilic polymers absorb water, 
so erosion takes place throughout the polymer matrix (homogenous erosion). Hydrophobic 
polymers will erode only at surface, or (heterogeneously), since water is excluded from the bulk 
of the matrix. In the pharmaceutical field however, hydrophobic polymer matrices are more 
useful as they exhibit near zero-order release kinetics. 
Several mathematical models have been developed to explain controlled release in 
erosion controlled systems. Erosion mechanism involves drug dissolution, polymer degradation, 
porosity creation, micro environmental pH change due to degradation, diffusion of drug in 
matrix, and autocatalytic effect during polymer degradation. Due to this complex set of 
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mechanisms, it is difficult to develop an accurate model that is able to predict all the mechanism 
contributions on drug release kinetics from an erosion controlled polymer. The models 
developed so far have been divided into empirical and mechanistic models. Empirical models 
are commonly developed for surface eroding systems that exhibit zero order releases, and do not 
take into account complex physiochemical phenomena. The mechanistic models on the other 
hand take into account physiochemical phenomena that involves diffusional mass transfer and 
chemical reaction processes. Empirical models consider the erosion process as a transport 
process of combined diffusion and chemical reaction processes, whereas mechanistic models 
consider erosion process as a random event. 
3.4 Swelling Controlled Systems 
Hydrophilic matrices incorporated with drug in which drug release is controlled by the 
inward flux of solvent molecules and subsequent swelling of the polymer matrix is considered 
swelling controlled systems. The impetus behind the swelling polymer is to provide more 
control over the release of drug when diffusivity in the matrix is low. In some polymers, the 
diffusivity is low and it is difficult for drugs to diffuse out. To this end, swellable polymers are 
used which, imbibe water and cause polymer disentanglement. Once the water is imbibed in the 
matrix, it decreases the polymer concentration and changes the level of polymer 
disentanglement. Once the chain disentanglement decreases, it also leads to matrix swelling that 
results in a “rubbery” region in which there is enhanced diffusion allowing easier movement of 
drug out of the matrix. In this system the release of the drug can be described by Fick‟s Law. 
However the deviation from the Fickian model is observed when drug release is controlled not 
only by the diffusion of the drug in the matrix, but also by polymer matrix entanglement and 
dissolution process.  
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The extent of swelling of the hydrophilic polymer depends on the composition of the 
polymer as well as the geometry of the gel.  There are several mathematical models derived for 
swelling controlled systems, mostly for cylindrical geometry, while other geometry models can 
be derived from these by transformation of coordinates [3.21, 3.9]. HPMC, PEG, PVA are 
examples of hydrophilic polymers. Peppas and Lee [3.7] developed a model that describes 
matrix swelling by account for swelling moving fronts. When the polymer network comes in 
contact with aqueous solutions, swelling occurs to achieve thermodynamic equilibrium due to 
the water concentration gradient. As water is imbibed in the gel, the glass transition temperature 
of the polymer decreases, and the polymer transforms from a glassy to a rubbery state, in which 
drug diffusivity is high. So during the whole swelling process, two different states, the “glassy 
core” and gel layer (rubbery), exist. Thus there also exist two moving fronts, the glass-rubbery 
front(R) and the rubbery solvent front(S).  During initial swelling, front R moves inward and 
front S outward. As soon as the polymer at interface S reaches its thermodynamic equilibrium 
with the surrounding medium, interface S starts dissolving, and front S moves inward. Both the 
fronts move inward, until the front R diminishes as the glassy core disappears. Eventually only 
R region is present and dissolution at interface S controls the shrinking process. On contact with 
water, the drug dissolves due to a concentration gradient between the interfaces of two states. 
If water penetration is negligible, polymer relaxation is negligible, and drug release is 
controlled by Fickian diffusion [3.1]. When the extent of swelling is large, polymer relaxation is 
dominant [3.22], and Case II transport characterizes drug release [3.22]. Drug release is 
generally zero order since it is controlled by the polymer dissolution process. In many polymers 
however, anomalous transport is observed, which has intermediate characteristics to these two 
extreme cases. Anomalous transport is actually a combination of Fickian diffusion and polymer 
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relaxation, occurring together, thus making it impossible to distinguish between them. There are 
several models found in the literature describing each of the above mentioned scenarios [3.15]. 
 
Figure 3.3 Schematic of one dimensional swelling process due to solvent diffusion and 
polymer dissolution as proposed by Lee. From Fig 5 in ref[3.1] 
 
Both empirical and mechanistic models have been developed to characterize drug release 
from hydrophilic polymers, or hydrogels. 
3.4.1 Empirical Models  
A simple empirical equation based on a  power law expression, relating fractional release of 
drug to the release time is one of the most widely used to interpret release data for non swellable 




= 𝑘𝑡𝑛   (3.5) 
Here n is the diffusional exponent. The value of n is an indication of the nature of transport 
occurring in the system. The power law equation is thought to be a superposition of two 
processes, Fickian and Case II diffusion. As the transport varies from Fickian (n=0.5) to Case II 
diffusion (n=1), the value of n varies as well. In between these two processes, anomalous 
diffusion is characterized by intermediate values of n (0.5<n<1) [3.15]. These values of n also 
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depend largely on the geometry of the polymer system in question. The table below shows 
different values of n, for different geometries in different transport regimes [3.15]. 
Table 3.1 Diffusional exponent and mechanism of diffusional release from various 
swellable controlled systems. From Table 1 in [3.15] 
                Diffusion Exponent(m) Mechanism 
        
Film Cylinder Sphere   
        
0.5 0.45 0.43 Fickian diffusion 
        
0.5<m<1.00 0.45<m<0.89 0.43<m<0.85 
Anomalous 
Transport 
        
1 0.89 0.85 Case-II Transport 
 
The Eq (3.5) has however been shown to be valid only for the first 60% of the total 
amount of drug released regardless of the geometry of the polymer [3.16]. Peppas [3.16] 
incorporated the aspect ratio in describing the controlled release system. The diffusional 
exponent n can be defined for Fickian diffusion as a function of the aspect ratio. According to 
this analysis, cylinders with an aspect ratio smaller than 0.2, have n equal to 0.45. An aspect 
ratio of 0.2 defines the maximum aspect ratio (2a/l) for which one dimensional diffusion in a 
cylinder is valid. Also to be noted is that particle size distribution also influences the value of n, 
and therefore the release behavior of the polymeric system [3.16]. 
3.4.2 Release from Swellable Devices 
The power law Eq (3.5) is used to describe release behavior of solutes in non-swellable 
devices. In most swellable polymer devices, however the rate at which the solvent enters the 
polymer might have a significant effect on the drug release. Thus in most swellable polymers, a 
combination of diffusion and macromolecular relaxation takes place and the drug diffuses with 
behavior indicated by the relative ratios of Fickian and relaxation. The modeling of these 
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devices, however are modeled via moving boundary problems. Crank [3.24] and Stefan-
Neumann [3.10, 3.14] have elucidated the difficulty of actually being able to obtain exact 
analytical solutions to the complicated equations for swellable devices. Thus one resorts to 
using numerical solutions. However the power law expression [3.17] can still be used to 
describe release data in these systems, as long as they swell only moderately in the presence of 
the penetrant. Mostly the polymer should not swell more than 25% of its original volume. As is 
the case with non swellable polymers, the diffusional exponent is greatly influenced by the 
geometry of the polymer, the value of n, and its limits for Fickian diffusion and Case-II 
transport for swellable systems (as shown in table (Table 3.1)). Similarly the particle size 
distribution changes the observed kinetics of the system, thus altering release behavior.  
3.4.3 Coupling of Diffusion and Relaxation for Anomalous Diffusion 
Fickian diffusion occurs by molecular diffusion of drug due to chemical potential 
gradient, whereas Case II relaxation release is due to the stresses and state –transition in 
hydrogels. Table [3.1] gives the various values of the exponent n for these two limiting states. 
Regardless of the geometry of the polymer, it can be seen that value of the exponent for Case-II 
diffusion is always twice that of pure Fickian diffusion. This observation was the basis for the 
development of the heuristic approach described below [3.22]. 
Alfred at al. [3.22] considered for the case of solvent transport in a polymer that two 
phenomena of Fickian diffusion and polymer relaxation can be considered to be additive, and 






2𝑚   (3.6) 
The first term on the left hand side of eq (3.7) is the Case-II relaxation contribution, where as 
the second term is the fickian diffusion term. The coefficient m is the purely diffusion exponent 
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for a device of any geometrical shape. From literature [3.17], the coefficient m was shown to be 
constant for any geometry in two regions. For aspect ratios 2a/l, varying from 0.1 to 100, m can 
be defined as in Eq (3.7) [3.15], 
 
Figure 3.4 Variation of the Fickian diffusional exponent m with aspect ratio 2a/l. From Fig 
3 in Ref[3.16] 
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𝑡0.45   (3.11) 
This equation can approximate the controlled release of active agent of disks with the given 
aspect ratios, under the condition of swelling controlled systems. Using the estimated 
parameters, 𝑘1 and 𝑘2 obtained from fitting data to above Eq (3.11), the ratio of relaxation and 
Fickian contributions can be calculated , and an idea of the dominant mechanism of transport 
can be deduced. Thus from the above equations, one can estimate the approximate contributions 
of the diffusional and relaxation mechanisms in an anomalous solute release process by fitting 
the data to the above models. 
3.4.4 Mechanistic Models 
Most of these empirical models are unable to describe how swelling affects the whole 
diffusional release behavior. Thus mechanistic models have been developed to describe the 
swelling behavior and its relation to controlled release. These models are based on moving 
fronts of the glassy and rubbery regions. The first model of swelling moving front was 
developed by Lee et al [3.7] for one dimensional swellable polymer systems without any drug 
loading (two component systems). Here the drug release is based on rational thermodynamics, 
including a complete viscoelastic description of the polymer matrix and concentration 
dependent diffusion coefficient of the drug [3.12]. Colombo et al [3.3] suggested that the gel 
layer consists of two regions of dissolved and undissolved drug gel layer thickness, where the 
distance of dissolved gel layer thickness is the important parameter that influences drug release. 
Harland et al [3.23] modified Lee‟s moving front model, by incorporating a third component, 
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the drug. Thus the three components are water (1), polymer (2) and drug (3). In this model, 
transport of drug and water is assumed to be Fickian. Narasimhan and Peppas [3.2] also used 
Lee‟s model with their own modifications. In this model, there are three components as well, 
with water and drug species formulated in volume fraction form based on Fick‟s second law. 
This model accounts for the superposition of Fickian diffusion and dissolution. Siepmann et al. 
[3.18] developed a model for drug release from HPMC tablets by combining diffusion , 
swelling, and dissolution mechanisms into Fujita –type exponential concentration dependent 
diffusivities. Drug and water diffusivities are exponentially dependent on the concentration of 
the swelling polymers due to their viscosity –inducing capabilities. Also, transport analysis is 
two dimensional in this model and integrated with the polymer swelling and dissolution. 
Siepmann et al. [3.19-3.20] further developed their previous model by utilizing Fick‟s second 
law in cylindrical coordinates and Fujita type exponential dependence of diffusion coefficients 
into a sequential layer model. The “sequential layer” model is performed in a computational grid 
and the modified structure of the grid is required for numerical analysis.  Swelling is considered 
to take place layer by layer, in which the outermost layer swells first followed by inner layers. 
The model is able to account for substantial changes in the volume of the system in the outer 
layer. This is a marked improvement in the model, as being able to predict volume changes 
gives an accurate idea of the changes in concentration of all species, and the mobility of the 
species. Further work is being done to develop an additional feature to this model, a glassy core 
region that will enable the observation of two moving fronts during the drug release process. 
3.4.5 Fundamentals of Diffusion 
In order for the release of drug to take place, the drug must move through the bulk of the 
polymer. This movement of the drug through the polymer matrix is known as diffusion. 
Diffusion is controlled by the mass transfer limitations at the boundary between the polymer and 
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its surroundings. On a macroscopic level, the diffusion of drug can be described by Fick‟s law 
of diffusion, stated as follows, for one dimensional transport [3.12]. 
 𝑗𝑖 = −𝐷𝑖𝑝
𝑑𝑐𝑖
𝑑𝑥







  (3.13)  
The above equations are valid for a thin planar geometry, and the diffusion coefficient is 
independent of concentration. Similar equations have been developed for other geometries, such 
as thick slabs, cylinders, and spheres [3.24]. The initial and boundary conditions are indicative 
of the experimental conditions imposed upon the drug release device. Several solutions for 
varying initial and boundary conditions have been published in literature [3.24]. 
To better predict the release of the drug using Fickian diffusion theory, a concentration 







 𝐷𝑖𝑝 𝑐𝑖 
𝜕𝑐𝑖
𝜕𝑥
   (3.14) 
The concentration dependent diffusion coefficient is affected by the structural characteristics of 
the polymer. Summary of various forms of diffusion coefficient is shown in Table 3.2 [3.12]. 
Several theories have been proposed in order to estimate the diffusion coefficient 
through a polymer carrier. One of the earliest approaches is the Eyring theory [3.4].  This theory 
represents the diffusion of solute through a medium as a series of jumps. . Fujita [3.5] used the 
idea of free volume in polymers to estimate a drug diffusion coefficient and found an 
exponential dependence on free volume. Yasuda and Lamaze [3.6] further modified Fujita‟s 
theory and proposed a molecular based theory. In this theory the normalized diffusion 
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coefficient is related to a degree of hydration, and free volume occupied by the swelling 
medium 
Table 3.2 Summary of drug diffusion coefficient equations. From Table 2 in ref [3.12] 
 
. Peppas and Reinhart [3.10] also developed a theoretical model based on the free 
volume of the polymer matrix. This theory applies to drug transport in highly swollen non 
porous hydrogels.  Another prediction of diffusion coefficient is using chemical engineering 
principles. The diffusion of a drug through a macro-or micro porous polymer is compared to the 
transport phenomena in porous rocks, ion exchange resins, and catalysts Thus several different 
theories have been developed to predict effective diffusion coefficients. 
3.4.6 Analysis of Drug Release for Non- Swellable and Swellable Polymers 
As noted above diffusion is the main mechanism of transport of the drug. There are 
several models to describe the kinetics of release of the drug, and models which estimate the 
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diffusion coefficients associated with controlled release. For non swellable polymers, Peppas 
developed simple equations to describe solute release. In this paper, we have dealt only with 
cylindrical hydrogels, thus will only elaborate on the equations describing release from 
cylindrically shaped polymer gels. 
 Release from Cylinders 
Consider  one dimensional radial release from a cylinder of radius a and length l, under perfect 













   (3.15) 
Where,  
t=0    0<r<a    C=𝐶1     ; 
t=0    r=a        C=𝐶0 









2𝑡   (3.16) 
𝛼𝑛  are the positive roots of 𝐽0 𝑎𝛼𝑛 = 0, 𝐽0 is Bessel function of the first kind of zero order, and 





















+ ⋯  (3.17) 
The above approximations are true only for a cylinder with one dimensional radial flow. For 
analysis of three dimensional release from a cylinder, a new approach was taken. Fu et al [3.5] 
57 
 
was the first to develop a model for three dimensional release, and it is elucidated below. Fick‟s 
law was applied to cylindrical coordinates with diffusion occurring in both the radial direction, r 
and the axial direction, z. This model is applicable to systems ranging from a flat disk to that of 
a cylindrical rod. 
 Three Dimensional Model 
Consider release from a disk of diameter 2a and thickness or length𝑙. The system can be defined 
in terms of an aspect ratio 2a/l. Initially the system is maintained at a constant uniform drug 
concentration, 𝐶1, and the surfaces are at  a constant drug concentration, 𝐶0. The drug diffusion 
coefficient D is assumed to be constant with diffusion in both the r and z directions and initial 















   (3.18) 
Where, 






      C=𝐶1 
                0<r<a 
t>0          z=±𝑙/2           C=𝐶𝑜  
                r=a 
 From drug concentration profile defined by the above diffusion equation, Fu et al [3.5], 
calculated the total drug transferred across the lateral surface and the two end surfaces of the 














2𝑡 ∞𝑚=0   (3.19) 







 𝛼𝑛   are the positive roots of of 𝐽0 𝑎𝛼𝑛 = 0, 𝐽0 is the zero order Bessel Function of the first 
kind and 𝑎𝛼𝑛  are the zeros of that function. 
The above general equation reduces to the one dimensional diffusion release equations 
from a slab for a→ ∞ , and from a long cylinder l→ ∞. Thus the above equation for three 
dimensional release with approximations can be reduced to the one dimensional release 
equations. 
The short time approximation for one dimensional release from a flat disk can be 











  (3.20) 
 Short Time Approximations 
For short times, an analytical solution can be derived for describing one dimensional 






















  (3.21) 
On substituting above Eq (3.20), (3.21) into Eq (3.19), we get 
𝑀𝑡
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  (3.22) 
This solution is actually a combination of the solutions of short time solutions for one 
dimensional diffusional release from the cylinder and the thin slab with an additional “coupling 
term” scaled according to the aspect ratio 2a/l. Thus this equation can be applied to all disk 
shaped polymers with any aspect ratio. Peppas [3.15] compared the short time solutions given 
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by Eq (3.21) and the exact solution Eq(3.20). He found that for the aspect ratios 2a/l>>1 and 
2a/l<<1 the short approximations is valid for the first approximations is valid for the first 65% 
to 70% of the total release of drug from the polymer carrier. Thus the short time approximation 
is valid for one dimensional diffusional release from cylinder (2a/l<<1) 
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Chapter 4 : Preparation of PEGDA               
Hydrogels and Study of Release Kinetics 
4.1 Overview 
PEGDA hydrogels were prepared in order to study it‟s suitability for biomedical 
applications. Swelling studies give an average mesh size, as well as a reasonable idea of the 
morphological structure of the gel. Diffusion studies with dyes can mimic controlled drug 
release studies. Thus swelling and diffusion studies together were an ideal combination to study 
the potential of these PEG hydrogels as drug delivery matrices, and as matrices for protein 
immobilization. Polyethylene glycol, with its hydroxyl moieties can be acrylated to form 
PEGDA (polyethylene diacrylate). Acrylate monomers are esters containing vinyl groups, that is 
two carbon atoms double bonded to each other, directly attached to the carbonyl atom. FTIR 
scans were used to determine the extent of acrylation, and C=C double bond conversion. The 
peaks in the absorbance spectra are an indication of the extent of conversion, the larger the 
magnitude of the peak, larger the extent of acrylation. As the molecular weight of the PEGs 
increases, the magnitude of the peak absorbance value at 1714cm-1 also increases. On exposure 
to UV radiation, the photoinitiator, photofragments to yield radicals. These radicals initiate 
polymerization, by attacking the C=C double bonds present in the acrylate groups. In linear 
chain formation, branched as well as crosslinked structures are also formed, thus forming an 
insoluble three dimensional polymer network. This polymer network is the hydrogel, which can 
be used as a matrix for drug delivery, and as a matrix for encapsulation of biological material. 
Cylindrical hydrogels were prepared since they were relatively easy to manufacture as well as 
analyze. These cylindrical gels were allowed to swell in an aqueous environment, and 
morphological parameters, such as molecular weight between crosslinks and mesh size, were 
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determined. Release studies of dye were then performed, by placing gels in an aqueous solution, 
and allowing the dye to diffuse out of the gel. The release data obtained were fit to various 
mathematical models, and diffusion coefficients of the dye were subsequently determined. 
4.2 Introduction 
Polyethylene glycol hydrogels are highly swollen biocompatible matrices. PEG is an 
FDA approved material which has found varied uses in the pharmaceutical and medical fields. 
Its biocompatibility, tendency to absorb water and flexibility make it one of the most widely 
used synthetic hydrogels. These PEG hydrogels have been used as drug delivery devices [4.17], 
as membranes for biosensors [4.13], as contact lenses [4.18] and for the encapsulation of islets 
for treatment of diabetes [4.19]. Many researchers have prepared PEG hydrogel networks 
fabricated from dilute solutions that were crosslinked using low energy light illumination with a 
photoinitiator [4.2], electron beam [4.6], or gamma irradiation [4.16]. Several PEG hydrogel 
applications such as for electrochemical [4.20] and optical biosensing [4.21] , drug delivery 
[4.5], and substrate materials for directed cell growth [4.22] use PEG formed by extremely rapid 
photopolymerization from highly concentrated solutions of PEG acrylates. However these gels 
may contain a large number of physical entanglements and microgels that can influence mass 
transfer within the gel.  
In this paper, the PEG hydrogels were formed from PEG acrylate solutions which were 
polymerized along with photoinitiator, upon exposure to UV radiation. A variety of 
photionitiators have been used by various researchers for this purpose. For our purposes, we 
chose a liquid photinitiator in order to ensure ease of mixing of precursor solutions. Also, care 
was taken so that the magnitude of UV radiation from the UV lamp exceeded the threshold 
value required to activate the photoinitiator. To mimic drug delivery of small proteins, 
fluorescein dye is used to study controlled release from hydrogel. Fluorescein dye was chosen, 
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because its excitation and emission spectrums are well defined and has been used in various 
similar studies [4.12]. The excitation and emission spectrum of the dye also did not interfere 
with the wavelengths of UV radiation required for polymerization.  
Various researchers have studied swelling and diffusion of solutes in different synthetic 
hydrogels such as PEG, poly (acrylic acid-g-ethylene glycol) [4.14], HPMC [4.15], PMMA 
[4.10]. Each synthetic material has different release characteristics depending on method of 
preparation, constituents, mode of polymerization, conditions of swelling and solute release, as 
well as mode of solute release. To better understand the release data obtained from experiments, 
the data were fit to various empirical and semi empirical mathematical models. Most models 
developed are based in some form on solutions of the Fickian diffusion equation [4.23]. The 
Higuchi model [4.24] is the most often used model to describe the release rate of solutes from 
gels. Also the power law model (Ritger-Peppas) [4.11], the Peppas and Sahlin model [4.9],and 
the Roseman and Higuchi model [4.25] are all semi-empirical models that have been used to 
describe release data from hydrogels. In our research the power law is the fundamental model 
used to determine the transport regime of the dye, and the Fickian diffusion equation is used to 
approximate a diffusion coefficient. The release data analysis is the first step in order to be able 
to predict the controlled release characteristics of these hydrogels. Once the kinetics of release, 
and, the mesh size are obtained, it becomes plausible to design a system, according to the mesh 
size required for the transport of specific sizes of protein, and uniform site specific release of 
drug. 
4.3 Materials and Methods 
4.3.1 Materials 
Poly (ethylene glycol) diacrylate with molecular weights 200, 400 were obtained from 
Polysciences (Warrington, PA). 0.1 molar phosphate buffered saline (PBS, pH 7.4) was 
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prepared from potassium phosphate monobasic, sodium phosphate, potassium chloride, and 
18megaohm deionized water via standard preparation method. Poly (ethylene glycol) (8000, 
10000, 14000, and 20000 molecular weight), fluorescein, acryloyl chloride, trimethylamine and 
diphenyl (2, 4, 6 trimethyl benzoyl phosphine oxide/2-hydroxy-2-methyl propiophenone 50/50) 
were all obtained from Sigma Aldrich Co. (St. Louis, MO). 0.2 micron Teflon membrane filters 
as well as glass membrane filters were obtained from Molecular probes (Eugene, OR). All other 
reagents and chemicals, unless specifically mentioned, were supplied by Sigma-Aldrich (St. 
Louis, MO).    
4.3.2 Preparation of PEGDA  
Poly (ethylene glycol) diacrylate (PEGDA) of molecular weights 8000, 10000, 14000 
and 20000 were prepared by acrylating the hydroxyl functionalities of dihydroxy PEG using a 
published protocol [4.7]. PEG (20g) was dissolved in 200 ml of dry benzene under nitrogen and 
heated at 40°𝐶 until fully dissolved. The solution was then allowed to cool to room temperature. 
The solution was placed in an ice bath, followed by addition of four fold molar excess (PEG 
hydroxyl groups) of acryloyl chloride and triethylamine. This mixture was then heated to reflux 
under nitrogen for 2 h, followed by stirring overnight under nitrogen at room temperature. Care 
was taken so that no moisture was allowed to disrupt the reaction in the reflux condenser. The 
solution was filtered, to remove the amine salts formed during the reaction. The polymer was 
precipitated in 2 L of hexane. The resulting precipitate was recovered via filtration, and then 
dried at room temperature to obtain the final product. The final product was then tested using a 
FTIR spectrometer (Nicolet 380) to determine degree of acrylation. 
4.3.3 Preparation of Hydrogel for Swelling Studies 
PEGDA (1 g), diphenyl (2,4,6 trimethyl benzoyl)-phosphine oxide/ 2-hydroxy-2-methyl 
propiophenone 50/50 (1 ml) (photoinitator), and 0.1 M phosphate buffer solution (1 ml), were 
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vortexed at high speeds in a centrifuge tube to form a solution. The PEG and the PBS were 
vortexed first to form a solution with photoinitiator added later to facilitate easier mixing. The 
lower molecular weights were vortexed vigorously as they were waxy in nature, and had a 
tendency to form a biphasic system with the PBS and photoinitiator. The solution was heated if 
necessary, in order to obtain a well mixed solution. The solutions were then poured into acrylic 
tubes (D = 1/4in, L = 2in), covered with parafilm at one end, and exposed to UV radiation 
(INTELLI-RAY 600, 600 Watt UVA, 115/230V) for a period of 40 seconds.  The dimensions of 
the cylindrical hydrogels formed were measured to ensure at most an aspect ratio of 0.2 [4.11]. 
This aspect ratio (2a/L) ratio is the maximum aspect ratio for which the assumption of one 
dimensional diffusion in a cylinder is valid [11]. 
4.3.4 Mesh Size Calculation 
In order to characterize the hydrogel structure, the molecular weight between adjacent 
crosslinks (𝑀𝑐), the mesh size(𝜉) and  polymer volume fraction in swollen gel (𝜈2,𝑠) were all 
determined experimentally. All the experiments were performed with cylindrical hydrogels, 
with aspect ratios  0.2. 
The cylindrical hydrogels were initially weighed after crosslinking.   The cylinders were 
then immersed in 10 ml of PBS solution and allowed to swell for one week. It is known that 
swelling degree increases up to a certain time and then becomes constant. This value of swelling 
degree is known as the equilibrium degree of swelling. The one week swell time allowed the 
gels to reach the equilibrium swell conditions, which was essential for the calculation of mesh 
size.  After a week, the gel was removed from the PBS solution, weighed, and allowed to dry at 
room temperature for three days. The hydrogel desorbed all the phosphate buffer solution, 
leaving only the crosslinked polymer. The final gels were then weighed. The following 
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measurements were taken for each hydrogel, and for each individual molecular weight gel 
[4.18]. 
𝑊𝑎 ,𝑟  = sample weight after crosslinking 
𝑊𝑎 ,𝑠  = sample weight after swelling 
𝑊𝑎 ,𝑑  = sample weight after drying 
These measurements were used to determine the volume of the hydrogel sample after 
crosslinking (but before swelling),𝑉𝑔 ,𝑟 , and after equilibrium swelling, 𝑉𝑔 ,𝑠 . The following are 
the equations used to calculate these volumes. 











  (4.3) 
Where, 
𝑉𝑝  = weight of dry polymer 
𝜌𝑎 ,𝑟 = 𝜌𝑝𝑒𝑔 𝑥𝑝𝑒𝑔 + 𝜌𝑝𝑕𝑜𝑡𝑜𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑜𝑟 (𝑝𝑖 )𝑥𝑝𝑖+𝜌𝑝𝑏𝑠 𝑥𝑝𝑏𝑠  
𝜌𝑎 ,𝑠 = 𝜌𝑝𝑒𝑔 𝑥𝑝𝑒𝑔 + 𝜌𝑝𝑕𝑜𝑡𝑜𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑜𝑟 (𝑝𝑖 )𝑥𝑝𝑖+𝜌𝑝𝑏𝑠 𝑥𝑝𝑏𝑠  
𝜌𝑎 ,𝑑 = 𝜌𝑝𝑒𝑔 𝑥𝑝𝑒𝑔 + 𝜌𝑝𝑕𝑜𝑡𝑜𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑜𝑟 (𝑝𝑖 )𝑥𝑝𝑖   
Here, 
𝜌𝑝𝑒𝑔  = density of PEG 
𝜌𝑝𝑕𝑜𝑡𝑜𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑜𝑟 (𝑝𝑖) = density of photoinitiator 
𝜌𝑝𝑏𝑠  = density of phosphate buffer solution 
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𝑥𝑝𝑖  , 𝑥𝑝𝑏𝑠 , 𝑥𝑝𝑒𝑔  are mole fractions of photoinitiator, PBS, PEG 
The above calculated values are then input into the equation for calculation of 𝑀𝑐  following a 






















  (4.4) 
Here χ (polymer solvent interaction parameter) = 0.55 and Mn is the average molecular weight 
of PEG before polymerization. The average mesh size of the polymer network 𝜉, was calculated 
as described by Peppas and Merril [4.18]. The root mean squared end-to end distance of a 
randomly coiled polymer bonds with a length 𝑙 and characteristic ratio 𝐶𝑛  was calculated as: 
  (𝑟2)1/2 = 𝐶𝑛
1/2𝑛1/2𝑙χ  (4.5) 




The average mesh size of the network was then calculated as, 
 𝜉 = 𝜈2,𝑠
−1/3(𝑟2)1/2 (4.6) 
4.3.5 Swelling Studies 
The cylindrical hydrogels, were placed in a known amount of PBS (10ml), and allowed 
to swell. The initial weight of the gel was compared to the swollen weight. This allows for a 
transient analysis of the swelling of hydrogel. Weight of the gel was taken every ten minutes. 
The PBS was absorbed in the gel thus increasing the weight of the gel with time until 
equilibrium swelling weight is reached. While weighing the gels, care was taken to remove the 




The following equation was used to determine the kinetics of the swelling process of these 
hydrogels [4.26]: 
 𝐹 =  
𝑊𝑠−𝑊𝑝
𝑊𝑝
 = k𝑡𝑛  (4.7) 
Where, 
F= g PBS/g polymer 
𝑊𝑠  = weight of swollen polymer at time t 
𝑊𝑝  = weight of the fry polymer at time t=0 
Here k and n are the swelling constant and swelling exponent, respectively. The above 
equation is however applied only to the first 60% of swelling. The swelling data obtained were 
fit to the above equation using POLYMATH (version 5.0) and values of n and k were 
calculated. 
Now for Fickian diffusion of PBS from the gels, we can approximate the diffusion 
coefficient for swelling of these cylindrical gels, allowing us to better control the mechanism of 
transport in these gels. The diffusion coefficients were calculated by using the following 
equation [4.26]: 
 ` F = 4 𝐷𝑡/𝜋𝑟2 1/2 (4.8) 
Here, 
D= coefficient of diffusion 
r= radius of the cylindrical gel 
In the above equation, radial diffusion is assumed as the sole form of diffusion, and all 
end effects are neglected. Also it is assumed that the diffusion mechanism is Fickian diffusion. 
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Using POLYMATH (version 5.0) approximate values of D (coefficient of diffusion)  were 
obtained and are compared.  
4.3.6 Preparation of Gels for Diffusion Studies with Dye 
For diffusion studies with the cylindrical hydrogels, a small molecular weight dye, 
fluorescein was used in order to mimic the release of a drug. Flourescein stock solution of 
concentration 120uM was prepared with PBS as the solvent. PEGDA (1ml or 1g), stock  
solution (1ml) and Photoinitiator (1ml) were mixed vigorously. This solution was then poured 
into acrylic tubes (D = 1/4in L = 2in), and polymerized via exposure to UV radiation for a 
period of 40 seconds. The same procedure was followed for all the different molecular weight 
PEGs. The gels were cut, and measured lengthwise to assure that the aspect ratio remained 
below the requisite value of 0.2. The stock dye solution was poured in a cuvette, and the 
fluorescence spectra were obtained. The spectrofluorimeter (OLIS DM 45 Spectroflourimeter) 
was used and dye solution was excited at 492nm while the emission was scanned from 500 to 
540nm. The fluorescence intensity at 514 was recorded. This reading was used as the initial 
fluorescence of the gel before dye release. 
4.3.7 Dye Release Experiments  
Dye release kinetics was studied for the range of PEG molecular weights. The 
cylindrical gel was placed in a cuvette containing 2ml of PBS solution. The cylindrical gel was 
placed in the cuvette in such a way so that the path of light through the bottom half of the 
cuvette would not be obstructed. The top portion of the cuvette was covered with parafilm. The 
cuvettes were then placed on a magnetic stirrer, in order to agitate the solution in the cuvette and 
facilitate the diffusion of dye from the gel into the solution. Thus, as the solution inside the 
cuvettes was stirred, the gel absorbed the PBS, and in turn released the dye trapped inside the 
gel. At intervals of 10 minutes, the cuvette was removed from the stirrer and a fluorescence 
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reading was taken. The excitation wavelength was 492nm and the emission was scanned from 
500 to 540 nm. The fluorescence intensity was recorded at 514nm. Thus the fluorescence 
intensity of the solution to which dye diffuses is taken over a period of time. These transient 
fluorescence intensity readings provide an insight into the diffusion mechanism of the dye. 
These reading are taken over a period of three hours, to ensure sufficient diffusion of the dye, 
and enough data points for further analysis. Care was taken to ensure that the gel did not 
obstruct the path of light during fluorescence readings. Also the stir plate speed was kept 
constant for all molecular weight PEGs. 
4.4 Mathematical Analysis of Drug Transport Mechanism 
In order to study the dye transport mechanism from the cylindrical PEGDA hydrogels, 
two different diffusion models were considered to fit the experimental data. Model 1 is 








 is the fractional release of the dye release, k is a constant, t is the release time, and n 
is the diffusional exponent that can be related to the drug transport mechanism. For a cylindrical 
hydrogel, when n=0.45, the dye release mechanism is Fickian diffusion. When n = 0.89, Case II 
transport occurs, leading to zero order release. When the value of n is between 0.45 and 0.89, 
anomalous transport is observed [4.9]. 
Model 2 is described by the Peppas-Sahlin equation (4.10), which accounts for the 





1/2 + 𝑘2𝑡 (4.10) 
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using the estimated parameters 𝑘1 and 𝑘2 obtained from the experimental data fit from the 
above equation (Eq 4.10), the ratio of relaxation (R) and Fickian (F) contributions were 







𝑡1/2  (4.11) 
Thus experimental release data was fit to both these models, Eq (4.10) and Eq (4.11), 
and the contributions of both relaxation and Fickian diffusion was calculated. Using these 
values, the dominant mechanism of transport was determined.  Experimental data was analyzed, 
and fit to Eq (4.10) and (4.11) using POLYMATH (version 5.0). Data are represented as the 
mean plus or minus the standard deviation of n independent measurements, where n = 3. 
4.5 Mathematical Analysis of the Drug Release Kinetics 
For one-dimensional radial release from a cylinder of radius a, under perfect sink initial 
and boundary condition; with a constant dye diffusion coefficient D, Fick‟s second law is 












  (4.12) 
Where  
t=0         0 < 𝑟 < 𝑎        𝐶 = 𝐶1 
t= 0       𝑟 = 𝑎                𝐶 = 𝐶0 
The solution to Fick‟s law under the above specified conditions for a long cylinder with end 









2𝑡  (4.13) 
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Where the terms 𝛼𝑛  are the positive roots of 𝐽0 𝑎𝛼𝑛  
𝐽0 is the Bessel function of the first kind of zero order and 𝑎𝛼𝑛  are the zeros of that function. On 
using a short time approximation for one dimensional release from a cylinder, the fractional 




= 4  
𝐷𝑡
𝜋𝑎2












The experimental data is fit to this Eq (4.14) using POLYMATH 5.0 and the diffusion 
coefficient D is the parameter determined from fitting.  
4.6 Results and Discussions 
4.6.1 Acrylation Chemistry 
Polyethylene glycol needs to be acrylated in order to make crosslinking possible. The 
vinyl polymer group, once attached to the PEG, will form crosslinks on exposure to UV light. 
To determine whether this reaction was successful, FTIR scans were performed on the material 
to determine whether double bond conversion had taken place. The figures (4.1), (4.2) below 
show the results. PEG 200 shows a significant peak at 1721 cm
-1
. This is representative of 
double bond conversion. The intensity of this peak is 0.261 absorbance units. PEG 10000 also 
shows a significant peak at 1711.69, again indicative of double bond conversion. The peak 
intensity is almost 0.068. 
4.6.2 Swelling Parameters 
Swelling parameters such as mesh size (ξ) and molecular weight between crosslinks 
(Mc) are determined from swelling experiments of PEG hydrogels. PEGs of different molecular 
weights were all studied, and their parameters calculated. The results for the above experiments 





 Figure 4.1 FTIR Spectra of PEG 200. Red -PEG, Blue-PEGDA  
 
 























































200 97.2 5.67 
400 197.6 8.53 
8000 3973 50.06 
10000 4998.75 72.44 
14000 6984.7 79.1 
20000 9994.2 97.05 
 
As can be seen, both the molecular weight between crosslinks and mesh size increase 
with increasing molecular weight of the PEG. This is expected, as increasing molecular weight, 
implies longer molecule, allowing more solvent to enter. This leads to widening of the mesh 
size. Figure (4.3) elucidates the relation between 𝑀𝑛  and Mc in these gels. 
 
Figure 4.3 Effect of average molecular weight on the molecular weight between crosslinks 
(Mc). The dotted line represents the linear trendline fit 
. 
The molecular weight between crosslinks, appears to increase linearly with increase in 
molecular weight of the gel.   The mesh sizes also increases relatively linearly with  

































Average molecular weight of PEG




Figure 4.4 Variation of mesh size with average molecular weight. The dotted line 
represents the linear trendline fit. 
increasing molecular weight.  As the Mc increases due to increased swelling, the mesh widens, 
and increases the mesh size of the gel. PEG 200 and PEG 400 have very small mesh sizes, and 
show negligible swelling of the gel.  These mesh sizes are small in comparison to the 
hydrodynamic diameter of most protein molecules, and thus may not be used for drug delivery. 
However the higher molecular weight PEGs show mesh size on the order of 90-100A which is 
closer to the diameter of several protein molecules. So diffusion of biomolecules into and from 
these large mesh size gels is possible. These higher molecular weight gels can be used as 
immobilization as well as drug delivery matrices.  
4.6.3 Swelling Studies and Analysis 
Mesh size data gives us an idea about which PEGs would be ideal for drug delivery of 
small proteins and other drugs based on their hydrodynamic radii. However size is not the only 
consideration when selecting an ideal biomaterial. It is important to know the degree of gel 
swelling, as it is critical in understanding the diffusion mechanism. For this purpose swelling of 




















each PEG gel was recorded as a function of time and analyzed. Table (4.2) shows the values of 
n and k obtained by fitting this swelling data to power law Eq (4.9). 
Table 4.2 n and k values obtained from power law fit 
PEG  
( MW) 
200 400 8000 10000 14000 20000 
n 0.47 0.439 0.547 0.4919 0.635 0.573 
95%  
Confidence 
1.72E-01 1.38E-05 8.80E-02 7.50E-02 2.08E-06 5.28E-02 
Variance 8.32E-06 4.12E-06 4.43E-03 4.26E-02 3.95E-03 8.79E-03 
              
k 2.09E-03 3.66E-03 1.09E-01 2.06E-01 9.16E-02 2.08E-01 
95% 
Confidence 
1.83E-03 1.79E-07 4.26E-02 1.19E-01 8.56E-07 3.44E-02 
Variance 8.32E-06 4.12E-06 4.43E-03 4.26E-02 3.95E-03   8.79E-03 
 
The values of k, the swelling constant gradually increases along with the molecular 
weight. The swelling constant represents the extent of swelling and, is dependent on the amount 
of solvent imbibed by the gel. As the mesh size increases, the swelling capacity of the gel also 
increases leading to higher and higher values of k. However PEG 14000 shows an anomalous k 
value of 0.091645 which is less than for PEG 10000. This is attributed to the fact that the nature 
of the gel after preparation was rubbery leading to erroneous results. The lower molecular 
weight PEGs, PEG 200 and 400 show n values close to 0.45, indicating that solvent diffusion 
can be described by Fick‟s law. PEG 8000, PEG 10000, PEG14000, PEG20000 were all found 
to have values of n in the range 0.45<n<0.85. According to Table (4.2), this implies anomalous 
diffusion takes place in these gels. Once the mechanism of swelling is determined, we were able 
to predict diffusion coefficients and thus examine the efficiency with which these gels can be 





Figure 4.5 Power law fits for different PEG 200 and PEG 400. The dotted line represents 
equation fit 
 
Fickian diffusion is approximated in all these gels, to allow calculation of diffusion coefficients. 
PEG 10000 and above have values of n much larger than 0.45, thus indicating a little Fickian 
contribution to the diffusion characteristics of the gels. 
Table 4.3 Variation of diffusion coefficient with molecular weight 
PEG(MW) D(mm2/min) Variance 
95% 
Confidence 
200 7.00E-06 7.00E-06 2.00E-06 
400 1.70E-05 4.00E-06 5.00E-06 
8000 3.56E-02 4.56E-03 2.68E-03 
10000 7.74E-02 5.29E-02 8.92E-03 
14000 5.53E-02 1.14E-02 5.49E-03 
20000 6.89E-02 1.45E-02 4.06E-03 
 
As expected, the diffusion coefficients increase with molecular weight, as the ease with which 
solvent molecules can diffuse increases. PEG 200 and PEG 400, owing to their low diffusion 































greater than that of PEG 10000, since PEG 14000 and PEG 20000 are not purely Fickian, their 
fit to the Fickian solution is unreliable. Thus the D values for these PEGs are inaccurate. The 
higher molecular weight PEGs are difficult to characterize, due to their non-Fickian character. 
4.6.4 Dye Diffusion Studies 
Dye diffusion is studied as a mimic of small molecules such as drugs; and to understand 
the diffusion characteristics of the molecule from the gels. First the dye diffusion data was fit to 
the power law expression (4.9). The table below shows the values of parameters n and k 
obtained by fitting diffusion data to Eq(4.9). As expected, the values of the swelling constant 
increases with molecular weight, owing to increase in the degree of swelling. PEG 14000 and 
PEG 20000 however show anomalous values for k. These higher molecular weight PEGs have 
such high degree of swelling, that the diffusion of the dye becomes almost linearly dependent on 
time. This causes experimental error in predicting the mechanism of diffusion thus showing 
erroneous values of k. 
Table 4.4 n and k values obtained from power law fit 
PEG(MW) 200 400 8000 10000 14000 20000 
              
N 0.543 0.421 0.43 0.5606 0.5315 0.739 
95% 
Confidence  1.13E-04 3.72E-04 1.67E-03 3.62E-02 7.69E-02 4.35E-02 
Variance 1.82E-04 3.70E-05 7.69E-04 2.92E-04 1.60E-05 5.00E-05 
                     
K 1.21E-02 2.88E-02 4.26E-02 3.43E-02 1.08E-02 1.55E-02 
95% 
Confidence  6.00E-06 5.20E-05 3.24E-04 6.32E-03 3.67E-03 2.91E-03 
Variance 1.82E-04 3.70E-05 7.69E-04 2.92E-04 1.60E-05 5.00E-05 
 
PEG 400 and PEG8000 have values of n in the range of 0.45, and Fickian diffusion can 
be assumed to be dominant in these gels. PEG 200, PEG 10000, PEG 14000, PEG 20000 have 
values of n indicating that diffusion in these gels is anomalous. As for swelling data, dye data 
80 
 
was fit to Eq(4.10), and (4.11) estimated values of the diffusion coefficient D were calculated. 
Table (4.5) gives values of k1 and k2 and Ratios F/R for each PEG. 
Table 4.5 Peppas equation parametes. 
PEG(MW) 200 400 8000 10000 14000 20000 
k1 1.39E-02 2.30E-02 3.48E-02 3.97E-02 1.86E-02 2.70E-02 
k2 8.31E-05 -2.80E-04 -3.80E-04 5.29E-04 8.19E-05 2.60E-03 
F/R 33.2 140 23.4 20.05 30.1 2.055 
 
All the PEGs except for PEG 20000 have a F/R ratio greater than 20, implying that 
Fickian contribution is at least 20 times that of relaxation. We can thus approximate all these 
gels to follow Fick‟s law of diffusion. PEG 20000 has an F/R ratio of 2, and its diffusion cannot 
be assumed to be predominantly Fickian. This is again caused by large degree of swelling, 
which makes the relaxation of the polymer the dominant mechanism of diffusion. Thus all PEGs 
except PEG 2000 can be assumed to follow Fick‟s law, and their diffusion data can be fit to 
Eq(4.14)  to obtain values of D (diffusion coefficient) 




200 4.69E-04 2.58E-05 2.58E-05 
400 4.54E-04 3.48E-05 1.72E-04 
8000 1.06E-03 1.67E-04 8.14E-04 
10000 5.74E-03 6.99E-04 0.001806 
14000 1.73E-04 1.15E-05 1.95E-05 
 
Diffusion coefficient increases with molecular weight, indicating increasing ease of 
diffusion of dye. As swelling of the gel increases (opening the mesh), it becomes easier for 
solute molecules to diffuse out of the gel. PEG14000 has a lower value of D than expected, as  
high degree of swelling causes the gel to not conform to Fick‟s law completely. The dye release 
81 
 
data for lower MW PEGs can be described by Fickian diffusion equations indicating that the 
diffusion of the dye is influenced only by concentration difference between the gel and its 
surrounding. In almost all cases, higher molecular weight PEGs (PEGs with MW >10000) are 
influenced by the relaxation of the gel, and Fick‟s law no longer applies.  
4.7 Conclusions 
Understanding the diffusion characteristics of polyethylene glycol involves not only 
understanding the structure of the gel and the mechanism of diffusion, but also being able to 
devise a simple method to predict the efficiency with which diffusion takes place. Mesh size 
calculation for these gels leads to the conclusion that the larger molecular weight gels would be 
good matrices for drug delivery due to their large mesh size. However, as the mesh size 
increases, it becomes difficult to find analytical solutions to help predict diffusion coefficients.  
Swelling experiments reinforce the dilemma surrounding these gels. PEG 14000 and greater 
show larger degree of swelling, and thus their diffusion coefficients are higher. However 
diffusion in these gels are highly anomalous, and influenced by the relaxation of the gel, so 
cannot be predicted using Fick‟s law. Using Peppas‟s equation, we can however develop a basis 
on which approximations can be made. In spite of the assumption of Fickian diffusion in these 
gels, in most cases, the results are unreliable. 
Diffusion of dye was studied, as it would mimic closely small sized drugs in the same 
size range. Dye diffusion was very low for PEG 200 and PEG 400 as the small mesh size 
hindered the passage of the dye. As the mesh size increased, it became easier for solute 
molecules to diffuse out of the gel, and the diffusion coefficient increased. For PEG 14000 and 
PEG 20000, the mesh size is so large, that dye diffuses out quickly and it is the relaxation of the 
polymer which determines the characteristics of diffusion. Even though dye diffusion is taking 
place in large quantities, it becomes difficult to analyze, and cumbersome to develop equations 
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for prediction of D. Thus a balance must be maintained for PEG hydrogels to be useful as 
biomaterial carriers. The gel must allow diffusion of molecules easily and quickly, and also the 
diffusion mechanism should ideally be Fickian to enable easy interpretation and analysis. So, a 
hybrid gel with intermediate properties might be the ideal material for drug delivery. 
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Chapter 5 : Study of Mixtures of PEGDA 
Hydrogels 
5.1 Introduction 
PEGDA hydrogels of different molecular weights have been researched widely. PEGDA 
has vastly different characteristics, depending on  molecular weight .The idea behind the study 
of mixture behavior was that a binary mixture of two different molecular weight PEGs could 
have combinatorial properties of its constituent PEGs. The properties of a particular gel matrix 
could thus be manipulated by using appropriate molecular weights in proportion to desired 
properties. So, combination mixtures of different molecular weight PEGs were studied, to 
determine their mesh sizes, polymer volume fractions, molecular weight between crosslinks, 
and swelling properties. Once various combinations had been studied, one particular 
combination was selected, in order to determine the dependence of mixture ratios on structural 
parameters, and thus swelling and diffusion properties. The mixture chosen was 200/14000 
which would adequately represent an intermediate molecular weight, as well as intermediate 
properties of both lower molecular weight 200 as well as higher molecular weight PEG 14000. 
Ratios of the two different molecular weight PEGS were widely varied to address a wide range 
of mixture conditions. Swelling parameters obtained were then studied, to determine whether a 
direct correlation existed between the ratio of PEGs, and the structural parameters of mesh size, 
and Mc. This would enable us to synthesize a gel of required intermediate properties by using 




5.2 Materials and Methods 
5.2.1 Materials 
Poly (ethylene glycol) diacrylate with molecular weights 200, 400 were obtained from 
Polysciences (Warrington, PA). 0.1 molar phosphate buffered saline (PBS, pH 7.4) was 
prepared from potassium phosphate monobasic, sodium phosphate, potassium chloride, and 18 
mega ohm deionized water via a standard preparation method. Poly (ethylene glycol) (molecular 
weights 8000, 10000, 14000, and 20000), acryloyl chloride, trimethylamine, and diphenyl (2, 4, 
6 trimethylbenzoyl)-phosphine oxide/2-hydroxy-2-methyl propiophenone 50/50 were all 
obtained from Sigma Aldrich Co. (St. Louis, MO). 0.2 micron Teflon membrane filters as well 
as glass membrane filters were obtained from Molecular probes (Eugene, OR). All other 
reagents and chemicals, unless specifically mentioned, were supplied by Sigma-Aldrich (St. 
Louis, MO).    
5.2.2 Preparation of Mixed PEGDA Hydrogels 
Mixtures of PEGDA were prepared in a 50/50 mass ratio. Various combinations of 
different molecular weight pairs were chosen, such that a broad range of mixtures could be 
examined.  The following PEGDA mixtures were prepared and investigated 
Table 5.1 Mixtures of PEGDA with its constituent molecular weights 
MOL WT(PEGDA) 
Sample PEG1 PEG2 
1 200 400 
2 200 8000 
3 400 10000 
4 200 14000 
5 400 20000 




5.2.3 Sample Mixture Preparation 
PEGDA 1 (0.5ml), PEGDA 2 (0.5ml), photoinitiator (1ml) and 0.1M phosphate buffer 
solution PBS (1ml) were combined and vortexed to obtain a well mixed solution. The solutions 
were heated, if necessary, in order to facilitate mixing. All combination mixtures were added in 
a 50/50 mass ratio, while the amount of photoinitiator, and PBS solution remained the same for 
all different molecular weight combinations. These solutions were then poured into acrylic tubes 
(D = 1/4 in L = 2in), in order to shape the gels in the form of long cylinders. These tubes are 
then sealed with parafilm at one end, and exposed to UV radiation (INTELLI-RAY 600, 600 
Watt, 115/230V) for a period of 40s. The dimensions of the cylindrical hydrogels formed were 
measured to ensure a maximum aspect ratio of 0.2. This aspect ratio (2a/L) of 0.2 is the 
maximum aspect ratio for which the assumption of one dimensional diffusion in a cylinder is 
valid [5.1]. 
5.2.4 Calculation of Mesh Size 
As with the individual molecular weight hydrogels, these combination hydrogels were 
subjected to swelling experiments. The cylindrical gels were weighed and placed in 10ml of 0.1 
M phosphate buffer solution. The gel was kept in the solution for a period of one week in order 
to ensure maximum uptake of solution, and equilibrium swelling. The gel was again weighed, 
and left to dry for 48 hours. Once the gel was completely dry, the dry gel was again weighed.  
The following parameters were then calculated: 
 𝑊𝑎 ,𝑟  = sample weight after crosslinking 
𝑊𝑎 ,𝑠  = sample weight after swelling 
𝑊𝑎 ,𝑑  = sample weight after drying 
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These measurements were used to determine the volume of the hydrogel sample after 
crosslinking (but before swelling), 𝑉𝑔 ,𝑟 , and after equilibrium swelling, 𝑉𝑔 ,𝑠 . The following are 
the equations used to calculate these volumes. 











  (5.3) 
Where, 
𝑉𝑝  = weight of dry polymer 
𝜌𝑎 ,𝑟 = 𝜌𝑝𝑒𝑔  1𝑥𝑝𝑒𝑔  1 + 𝜌𝑝𝑕𝑜𝑡𝑜𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑜𝑟 (𝑝𝑖 )𝑥𝑝𝑖+𝜌𝑝𝑏𝑠 𝑥𝑝𝑏𝑠 + 𝜌𝑝𝑒𝑔  2𝑥𝑝𝑒𝑔  2 
𝜌𝑎 ,𝑠 = 𝜌𝑝𝑒𝑔  1𝑥𝑝𝑒𝑔  1 + 𝜌𝑝𝑕𝑜𝑡𝑜𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑜𝑟 (𝑝𝑖 )𝑥𝑝𝑖+𝜌𝑝𝑏𝑠 𝑥𝑝𝑏𝑠 +  𝜌𝑝𝑒𝑔  2𝑥𝑝𝑒𝑔  2 
𝜌𝑎 ,𝑑 = 𝜌𝑝𝑒𝑔  1𝑥𝑝𝑒𝑔  1 + 𝜌𝑝𝑕𝑜𝑡𝑜𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑜𝑟 (𝑝𝑖 )𝑥𝑝𝑖  +𝜌𝑝𝑒𝑔  2𝑥𝑝𝑒𝑔  2 
Here, 
𝜌𝑝𝑒𝑔  1  = density of PEG mol wt 1 
𝜌𝑝𝑒𝑔  2  = density of PEG mol wt 2 
𝜌𝑝𝑕𝑜𝑡𝑜𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑜𝑟 (𝑝𝑖) = density of photoinitiator 
𝜌𝑝𝑏𝑠  = density of phosphate buffer solution 
𝑥𝑝𝑖  , 𝑥𝑝𝑏𝑠 , 𝑥𝑝𝑒𝑔1,𝑥𝑝𝑒𝑔2, are mole fractions of photoinitiator, PBS, PEG (mol wt 1), PEG (mol wt 
2) 

























  (4) 
Here, χ (polymer solvent interaction parameter) = 0.55 and Mn is the average molecular weight 
of PEG mixture. The average mesh size of the polymer network was calculated as described by 
Peppas and Merrill [5.2]. The root mean squared end-to end distance of a randomly coiled 
polymer bonds with a length l and characteristic ratio 𝐶𝑛  was calculated as: 
 (𝑟2)1/2= χ𝐶𝑛
1/2𝑛1/2𝑙 (5.5) 




The average mesh size of the network was then, 
 𝜉 = 𝜈2,𝑠
−1/3(𝑟2)1/2 (5.6) 
5.2.5 Study of Swelling Characteristic of PEG 200/14000 Mixture 
Once the mesh sizes for various mixtures of different molecular weight PEGs were 
calculated, one combination mixture was chosen and studied in detail. The mixture chosen was 
200/14000 PEGs as it would provide the largest range of properties. Different concentration 
combinations of this mixture were prepared, and a wide concentration range was chosen. The 
following hydrogels with given mass fractions of 200/14000 peg were prepared as mentioned 
earlier (Section 4.3 Chapter 4). Each mixed gel was weighed and placed in 10ml of 0.1 M PBS 
solution. The weight of the gel was taken every 10 minutes for a period of three hours, taking 
care that no PBS remains on the surface of the gel during measurement. After the readings were 
taken, the gel was returned to the PBS solution for a week to ensure maximum absorption of 
solution into the gel. 
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Table 5.2 Various concentration combination of PEGDA mixture 200/14000 




1 0.1 0.9 
2 0.2 0.8 
3 0.3 0.7 
4 0.4 0.6 
5 0.5 0.5 
6 0.6 0.4 
7 0.7 0.3 
8 0.8 0.2 
 
Once this equilibrium swelling state was reached, the gel was taken out of solution, 
weighed and allowed to dry in air. After 48 hours, all the water had been desorbed and only the 
crosslinked polymer remained. At this point the gel was again weighed. This allowed for the 
calculation of both the transient swelling behavior and the mesh size for each combination gel 
sample. From the equilibrium swelling data, the mesh size was calculated as mentioned above 
(Eq (3.6)), accounting for the changes in mass fractions of the constituents in the gel. The 





 =k𝑡𝑛  (5.7) 
Where, 
F= g PBS/g polymer 
𝑊𝑠  = weight of swollen polymer at time t 
𝑊𝑝  = weight of the fry polymer at time t=0 
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Here k and n are the swelling constant and swelling exponent respectively. The above 
equation can only be applied to the first 60% of swelling. The swelling data obtained was fit to 
the above equation using POLYMATH (version 5.0) and values of n and k were calculated. 
For Fickian diffusion of PBS from the gels, we can approximate the diffusion coefficient 
for swelling of these cylindrical gels. This allows for a better understanding and tailor ability of 
the transport properties of these gels. The diffusion coefficients were calculated by using the 
following equation: 
 F=4 𝐷𝑡/𝜋𝑟2 1/2 (5.8) 
Here, 
D= coefficient of diffusion 
r= radius of the cylindrical gel 
In the above equation, radial diffusion is assumed as the sole form of diffusion, and all 
end effects are neglected. Also it is assumed that the diffusion mechanism is Fickian .Using 
POLYMATH (version 5.0), approximate values of D (coefficient of diffusion) were obtained 
and analyzed.  
5.3 Results and Discussion 
Mixtures of different molecular weight PEGs were studied in an attempt to produce 
hybrid gels, with desired structural properties and swelling behavior. It was seen previously 
[Chapter 4, Section 4.6] that the properties of PEG vary drastically with molecular weight. The 
idea is to design a gel with adequate mesh size to facilitate the diffusion of penetrant to and 
from the gel, but simultaneously control the release behavior of a desired compound. 
Additionally the design should allow for simple and accurate prediction of diffusion 
coefficients. PEG mixtures of various molecular weights, were studied via swelling 
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experiments. A linear relation between mixture swelling properties, and individual PEG 
properties was established. It was apparent that changing quantities of constituent components 
had a significant effect on the properties of the gel. One combination mixture was selected, and 
its individual PEG ratios varied, to analyze the effect of changing PEG ratios. The diffusion 
regimes of these gels, and their approximate diffusion coefficients were also calculated as the 
first step in determining suitability of these gels as drug delivery devices. 
5.3.1 Mesh Sizes for Different Mixture Combination 
Different mixture combinations of polyethylene glycol with differing molecular weights 
were studied for swelling behavior. A wide range of molecular weights was used to obtain a 
broad range of data. The constituting PEGs were in equal quantities in the gel. Mesh sizes of 
each combination gel was calculated from swelling studies using Flory-Rehner theory [5.4]. The 
mesh sizes were found to increase with the molecular weight between crosslinks (Mc). There 
seemed to be a direct relation between the mixture Mc, and the Mc of the constituent molecular 
weight gels. Results from the swelling experiments are as shown in Table (5.3). The mesh sizes 
calculated for the mixtures from experimental data were compared with mesh sizes calculated 
from theoretical data. From the homogenous hydrogels (Table (5.1)), the theoretical mesh sizes 
for the mixtures were calculated as the weighted average of the individual mesh sizes of the two 
PEG gels. The theoretical molecular weight between crosslinks was also calculated similarly by 
averaging the individual Mc‟s. The following figure (5.1) compares theoretical and calculated 
mesh sizes. In order to simplify comparison of mesh sizes, each mixture was represented by the 
weighted average of its constituent molecular weight PEGs. The above figure shows that for 
most of the combinations, the theoretical and calculated mesh sizes are almost equal. However 
as the average molecular weight of the mixture increases, so does the disparity in the values of 
the mesh sizes.   
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Table 5.3 Mesh sizes and molecular weight between crosslinks for all mixture 
combinations 
                 
PEG(MW)       
mesh size(𝑨 ) 
(Experimental) Mc(experimental) 
 










  200 400 7.32E+00 1.48E+02 7.10E+00 1.47E+02 
200 8000 2.96E+01 1.96E+03 2.79E+01 2.04E+03 
200 14000 3.96E+01 2.56E+03 4.05E+01 2.60E+03 
400 10000 4.32E+01 3.45E+03 4.24E+01 3.54E+03 
400 20000 8.21E+01 5.10E+03 5.28E+01 5.10E+03 
10000 20000 9.34E+01 7.50E+03 8.47E+01 7.50E+03 
 
 
Figure 5.1 Comparison of theoretical and calculated mesh sizes for all mixtures. The 
theoretical mesh size is the weighted average of individual PEG mesh sizes 
 
For combinations which involve PEG 20000, it is seen that there is a significant 
difference between calculated and experimental values. The experimental values are of a higher 
value than the expected theoretical values. That is when two PEGs of different molecular weight 



















Average molecular weight of mixtures







combination of the mesh sizes of the two PEGs in question. However the relation is not so 
simple for higher molecular weight combinations. Gels involving PEG 20000 have a larger 
mesh size than expected. This is probably due to the fact that PEG 20000 swells to a large 
degree, overpowering the affects of any other PEG, leading to large mesh sizes. For the 
combination of PEG 20000 and PEG 200, the theoretical expected mesh size is 85.6𝐴 , 
compared to an actual mesh size of 93.4 𝐴 . This is a large variance, and is probably due to the 
fact that the contribution of PEG 200 was completely overshadowed by the swelling capacity of 
the PEG 20000 thus leading to an overall net higher mesh size. In the case of PEG 10000 and 
20000 mixture, the discrepancy still exists, but to a lesser degree. Both PEG 10000 and 20000 
swell, thus the PEG 20000 does not completely dominate the swelling process. However it does 
seem to have some semblance of control, as the mesh size is again larger than expected.  These 
results show that mesh sizes of combination PEGs, can be influenced by one component more 
than the other. 
In addition to mesh size, the molecular weight between crosslinks is another swelling 
property which provides insight into hydrogel characteristics. The figure below shows a 
comparison between theoretical and calculated mesh sizes for the given mixtures. Once again 
the mixtures are represented as average molecular weights of constituent PEGs. The theoretical 
Mc‟s we obtained by the same method as the mesh sizes. The above figure (5.2) shows both the 
calculated and theoretical values of 𝑀𝑐 . They are almost identical, indicating that there must be 
a linear relation individual 𝑀𝑐  of PEGs, and the mixture 𝑀𝑐
𝑚𝑖𝑥
. It appears that combining the 
two PEGs, gives the same 𝑀𝑐
𝑚𝑖𝑥
 as the simple average of the two individual PEGs. However it 
is difficult to draw conclusions as to the combined behavior of these gels, from the above data, 




Figure 5.2 Comparison of theoretical and experimental Molecular weight between 
crosslinks for mixtures. The theoretical values are weighted averages of the individual 
PEG Mc values 
 
.  . From the above data, with equal amounts of both PEGs in the mixture, we are unable to 
determine if varying the amounts of PEG, still supports a linear relation between the weighted 
individual  𝑀𝑐  and 𝑀𝑐
𝑚𝑖𝑥
.  For a complete analysis of the mixture behavior, a single mixture 
combination was chosen, and the amounts of the individual PEGs were varied. 
5.3.2 Variation of Mass fractions in Mixture 
One mixture combination was chosen, for further study of gel behavior. The mixture 
chosen was that of PEG 200 and PEG 14000. The above mixture provided the broadest range of 
gel behavior, ranging from low molecular weight 200 to high molecular weight PEG 14000. 
PEG 14000 was preferred over PEG20000 due to the excessive swelling presented by PEG 
20000. The mass fractions of the mixtures were varied and the resulting gels were analyzed. The 
concentration of the gels is given in Table (5.2). The results of the above experiments are as 
shown in figures (5.3). The above curve demonstrates that there exists a linear relation between 
the theoretical Mc calculated from individual PEG data and mixture‟s net Mc. The theoretical 
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Figure 5.3 Comparison of theoretical and experimental Mc (mixture) with variation of 
mass fractions of constituent PEGs. The increasing mass fractions represented are those of 
PEG 200. 
 
.  We can see that both the calculated and theoretical values overlap, confirming the 
existence of a linear relationship between the mixture Mc, and the individual Mc‟s. Table(5.4) 
shows both Mc values. 
Table 5.4 Table of calculated and experimental values of Mc for each mixture 







0.1 6.25E+03 6.30E+03 
0.2 5.53E+03 5.61E+03 
0.3 4.83E+03 4.92E+03 
0.4 4.17E+03 4.23E+03 
0.5 3.44E+03 3.54E+03 
0.6 2.84E+03 2.85E+03 
0.7 2.03E+03 2.16E+03 
0.8 1.42E+03 1.47E+03 
 




𝑃𝐸𝐺2𝑥𝑃𝐸𝐺2   (5.9)   
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are the individual molecular weight between crosslinks for the constituent PEGs in the mixture. 
𝑥𝑃𝐸𝐺1 and 𝑥𝑃𝐸𝐺2 represent the mass fractions of the individual PEGs in the mixture. This 
equation is valid for the complete range of combination mixtures, and shows that one can 
predict the  𝑀𝑐
𝑚𝑖𝑥   if the mass fractions of the constituent PEGs is known. 
Another important parameter that was investigated with mass fraction variance was the 
mesh size. The figure (5.4) below shows the behavior of mixture mesh sizes with variance in 
mass fractions of its constituent PEGs. It is clear that as the fraction of PEG200 increases, the 
mesh size decreases. This is expected as more of the PEG 200 is incorporated, the properties of 
the mixture gel is dominated by the effects of the PEG 200 faction. From earlier analysis, it is 
known that PEG 200 has negligible swelling capacity due to its very small mesh size.  
 
Figure 5.4 Effect of changes in mass fraction ratios on the mesh size of the mixtures. The 
trend line shows a linear fit. 
 
Thus, the results prove that the mixture behavior is influenced by the ratio of the 
amounts of individual PEGs. So a gel can be tailor-made to exhibit certain properties and 


















Mass Fractions of PEG 200
Mesh size vs mass fraction(200/14000)
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behavior, by just simply altering the quantities of individual PEGs. This becomes a very useful 
tool when designing drug delivery matrices with pre-determined structural characteristics. 
5.3.3 Swelling Properties of Mixture 
The mixture combination of PEG 200 and PEG 14000 was studied, for swelling 
behavior. From the mesh size data obtained above, it was clear that as the mass fractions were 
varied, the properties of the gel mixture changed dramatically. Swelling of the gel, and study of 
the swelling parameters, gives us a detailed picture of how these properties of the gel change. 
Additionally, the swelling data also tells us how diffusion coefficients of these mixtures vary. 
The swelling behavior of these gels in the presence of PBS was investigated.  The degree of 
swelling of the gel (F) with time was recorded with time, and is shown below in figures [5.5] 
and [5.6]. Figure (5.5) represents swelling curves for the mixtures with lower mass fractions of 
PEG 200. 
 
Figure 5.5 Swelling of mixtures with time. The mixtures represented here are for PEG 200 
mass fractions from 0.1 to 0.5 
 
Ranging from mass fractions 0.1 to 0.5, the curves show significant swelling of the gel 
with time. As the mass fraction of PEG 200 increases, the degree of swelling decreases. This is 






































as PEG 200, and thus swells to a much lesser degree. Figure (5.6) represents the swelling curves 
for mixtures with higher mass fractions of PEG200 ranging from 0.5 to 0.8. In figure (5.6), we 
expect that as mass fraction of PEG 200 increases, and that of PEG 14000 decreases, the degree 
of swelling should decrease. However there is no such distinct trend observed for the higher 
mass fractions of PEG 200. This may be due to the fact that the swelling degree substantially 
less. While a trend is difficult to quantify, it is noted that the degree of swelling is much less for 
lower mass fractions as expected. Further analysis of the above swelling data, was performed by 
fitting the above data to Eq(5.7), to determine the mechanism of transport for the mixtures. 
Table (5.5) shows values of n and k for each mixture. The values of n obtained from the data 
fitting gives a relatively good estimation of the transport behavior of the gel. . For mixtures with 
lower mass fractions of PEG 200, the values of n are quite large ranging from 0.842 to 0.6285. 
 
Figure 5.6 Swelling of mixtures with time. The mixtures shown are gels with PEG 200 
mass fractions ranging from 0.5 to 0.8 
 


































Table 5.5 Values of n and k obtained from fitting swelling data to power law expression. 
The values are shown along with the variance and 95% confidence limits of the fit. 
Mass 
fraction 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 
(PEG 200)                 



























































































. These values are close enough to the value 0.89, to assume Case-II type diffusion 
dominant in these gels. This is expected, as larger mass fractions of PEG 14000, leads to larger 
mesh sizes and large degrees of swelling. Consequently, polymer relaxation becomes dominant. 
The mass fractions of 0.3 and 0.4 have intermediate values of n.  Thus these gels exhibit 
anomalous diffusional behavior, meaning that neither Fickian diffusion nor polymer relaxation 
is dominant. For higher mass fractions (greater than 0.5), we finally start seeing the effects of 
Fickian diffusion. The mesh size is small enough such that diffusion of penetrant follows Fick‟s 
law. In these mixtures, the swelling of the gel is relatively small, indicating polymer relaxation 
is negligible. As PEG 200 characteristics becomes dominant in the gel mixture, the gel diffusion 
characteristics becomes dominated by Fick‟s law. This is the reason for the dominance of 
polymer relaxation in the gel. However for the higher mass fraction (0.7, 0.8) one can see that 
the gel swells to a much lesser degree, thus Fickian diffusion is the dominant mode of transport 
For intermediate mass fractions, it is seen that the curves overlap and exhibit intermediate 




Figure 5.7 Curve fitting of mixtures to power law expression. The mass fractions 
represented here are that of PEG 200. The dotted line represents the fitted data, while the 
markers represent experimental data 
 
It is evident then, that by controlling the ratios of mixture constituents, one can tune the 
gel to operate in any required diffusion regime. 
For the gels in which diffusion is predominately Fickian, we can fit the swelling curves 
to known equations (5.8), to obtain approximate diffusion coefficients. Prediction of diffusion 
coefficients is essential for design of drug delivery systems.  Thus the higher PEG 200 mass 
fraction gels were all fit to Eq (5.8), and parameter D (diffusion coefficient) was estimated. The 
following table (5.6) gives the values of D obtained after non linear regression was performed 
on the swelling data. 
Table 5.6 Diffusion coefficients for mixtures whose n value is close to 0.45 
Mass fraction (PEG 200) 0.5 0.6 0.7 0.8 
D(mm2/min) 1.42E-03 3.70E-03 2.62E-03 1.16E-03 
95% confidence 8.99E-05 2.94E-04 2.68E-04 7.17E-05 







































For mass fractions of 0.7 and 0.8, we see that the diffusion coefficient is small; this is 
due to its small mesh size. The mesh size in these cases becomes so small, that penetrant 
diffusion becomes difficult.  Thus if we can operate in the Fickian regime, and control mesh 
size, so as to allow significant diffusion to take place ,  a system with the perfect combination of 
controlled release, and large diffusion coefficients becomes possible. 
5.4 Conclusions 
It has been demonstrated that binary mixtures of PEGs, can be manipulated to exhibit 
certain characteristics by varying the PEG ratios. The swelling parameters mesh size and Mc 
vary greatly with constituent PEG molecular weight as well as concentration. The relationship 
being linear in nature becomes easy to interpret as well as predict. A gel can be prepared, by 
combining PEGs of two different molecular weights to obtain an intermediate gel that would 
possess accurate structural strength as well as diffusive properties. The gel can be further fine 
tuned for required characteristics by varying the ratios in which PEG is mixed.  Combining the 
PEGs in this way  enables researchers to incorporate favorable properties of large molecular 
weight PEGs (easy path for diffusion) as well as lower molecular weight PEGs (tight network, 
Fickian diffusion). This intermediate network structure in gel will be easy to analyze as Fickian 
diffusion is well documented in literature. It will also be of suitable mesh size, so that degree of 
swelling does not overcome the structural integrity of the gel, allowing easy handling of the 
matrix. One only needs to know the required mesh size and Mc ideal for drug delivery, the rest 
is just predicting from the linear relation which PEGs to use and in how much quantity. In most 
cases today, the required structural strength and penetrant mobility in the gel is obtained by 
adding crosslinking agents, or comonomers. These chemical are an additional cost, and in some 
cases can adversely affect the integrity of the gel.  Thus a method to use PEG, and vary only the 
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molecular weight and PEG quantity is a simple and cost effective way to create gels for drug 
delivery.  
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Chapter 6 : Summary and Future Work  
6.1 Summary 
Hydrogels are three dimensional crosslinked matrices which have recently become one 
of the most widely used material for biomedical applications. The ability of the gel to imbibe 
biological fluids accounts for its biocompatibility and its use in varied clinical applications, 
ranging from drug delivery carriers, encapsulation matrices, and food additives.  Drug delivery 
is one of the most prominent fields of research today, and the development of biocompatible, 
flexible and strong materials is one of the main concerns. Hydrogels are thus ideal materials for 
these applications. For development of efficient hydrogel based drug delivery devices, it is 
imperative that we understand the morphological structure, and the diffusional behavior of 
various solutes into and from the gels. Several monomers have been used as raw material for 
these hydrogels, ranging from PGLA to novel materials that exhibit specific predetermined 
properties. Hydrophilic polyethylene glycol is one of the most common hydrogel monomers, 
and researchers have utilized its „stealth‟ properties to develop several PEG –based drug 
delivery devices. This begins to characterize the significant properties of PEG by varying its 
molecular weight and determining the variation in its diffusional properties. PEG hydrogels are 
greatly affected by their swelling ability in water, thus a thorough study of its swelling 
properties was conducted. It is the nanostructure of the gel which influences its swelling and 
diffusional ability, and, therefore, study of the gel mesh structure was also an important factor in 
determining the characteristics of the gel.  To determine how efficiently certain biomoleules 
would diffuse from the gel, Fluorescein dye molecules were used to mimic this release process. 
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fluorescein molecules are small size molecules similar to several small drugs used for treatment 
of different ailments.  
 It was seen that PEG hydrogel properties vary significantly with molecular weight. The 
mesh size of the gels increases almost linearly with molecular weight. The mesh sizes range 
from 5 to 100 Angstrom units. Since most proteins have diameters ranging from 10 to 50 𝐴 , 
they would be able to diffuse into and out of these gels.  Swelling studies revealed that degree of 
swelling also increases with molecular weight. As the mesh size increased, more solvent was 
allowed to diffuse into the gel, thus increasing its swelling capacity. The lower molecular 
weight PEGs swelled in accordance with Fick‟s law. As swelling capacity increased, the 
relaxation of the gel became an important factor, and the diffusional transport mechanism 
became anomalous. PEG 20000 was almost completely dominated by the relaxation of the gel, 
and tended towards Case-II diffusion. Several analytical solutions have been formulated for 
predicting diffusion coefficients, however such solutions are not so simply available for 
anomalous and Case –II type diffusion problems. Diffusion studies with fluoroscein dye 
confirmed similar diffusive characteristics for the PEG gels. So gels need to be developed which 
would have large mesh sizes, and yet have diffusion characteristics that can be easily formulated 
and predicted.  
In search of these balanced gels, mixtures of PEG were studied. Combinations of 
different PEGs in equal quantities were subjected to swelling studies to determine their 
nanostructure as well as swelling behavior. The mixture Mc and the Mc‟s of the individual 
PEGs were linearly related. It was shown that the mixture Mc was the same as the average of 
the individual Mc‟s. The mesh size of the mixtures was linearly related to the individual PEG 
mesh sizes, showing deviation from linearity only in mixtures involving PEG 20000. This 
aberrant behavior is attributed to the large swelling degree of PEG 20K, whose effect 
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overpowers that of any other molecular weight PEG. All these mixtures contained PEGs in 
equal quantities, thus the effect of changes in concentration of constituent PEGs was not 
evaluated. To this end, PEG 200 and PEG 14000 were combined in different proportions to 
determine its effect on the mesh data, as well as swelling behavior. It was seen that there is 
indeed a linear relationship between mixture Mc and individual Mc. The mixture Mc is 
equivalent to the addition of the weighted averages of the constituent PEG Mc.  Also the mesh 
size of the gel increased (or decreased) with the increase in mass fraction of PEG 14000(or PEG 
200), indicating increasing effects of dominating PEG in the properties of the mixture. These 
simple linear relationships make it easy to fine tune gels in accordance with required properties 
of gels for use in drug delivery.   
Mechanism of swelling is another important factor in determining suitability of gel as a 
drug delivery matrix. It was determined that for intermediate mass fractions, 0.5,0.6,0.7 of PEG 
200, the effect of PEG 14000 is such that it allows easy penetration of solvent, however the 
effect of PEG 200 makes the diffusion mechanism predominantly diffusion, dominating the 
relaxation of the gel. Thus it has been shown that combining different molecular weight PEGs in 
correct proportion forms a gel with exact mesh size, structural properties as well as diffusion 
characteristics which are easy to analyze and interpret. These hybrid gels can thus be custom 
made, according to requirements of particular drug to be delivered, site of delivery, and mode of 
delivery. This approach of mixed PEG gels may be part of an avenue of research helping to 
create novel biomaterials with specific properties, specially designed for simple and effective 
drug delivery. 
6.2 Future Work 
This paper attempts to characterize the diffusion characteristics of PEG hydrogels for 
different biomedical applications. We have considered that diffusion from a cylinder is one 
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dimensional only, neglecting the effects of axial diffusion. The next step in this study would be 
to use models, such Siemann and Peppas model (sequential layer) which accounts for analyte 
transport in both radial and axial directions. These empirical models are, however, unable to 
fully explain how swelling affects drug release, thus mechanistic models that have been 
elucidated in review articles could be used. These models would be able to predict accurately 
the diffusion of penetrant from a cylinder without the difficulty of analyzing anomalous 
diffusion results. Even though these mechanistic models are difficult to solve numerically, they 
are superior in their accurate estimation of parameters. 
Diffusion of dye gives us an estimate of the diffusion of small drugs and proteins from 
the gel. If we are to fully understand the potential of these materials for drug delivery, diffusion 
of small and, larger molecules (immunoglobins), must also be studied. Peppas and other 
researchers have studied the diffusion of such molecules from PEG hydrogels, but have done so 
for only selected homogenous molecular weight PEGs. Similar studies on the combination 
mixtures [Chapter 5] could provide insight into the usefulness of these mixtures for real time 
drug delivery applications. If the mixtures prove useful as diffusion carriers, then custom made 
PEG hydrogels could be manufactured according to exact specifications and requirements.  
Furthermore, ternary PEG mixtures could be used to further tune properties of the PEG gel, and 
investigated for further simulated drug delivery. 
Once the analysis of these gels are complete, the final goal would be to formulate a 
mathematical model for PEG mixtures taking into account axial diffusion, as well as anomalous 
diffusion characteristics, and unifying all data obtained to a single model that can predict the 
diffusion characteristics of any penetrant of given hydrodynamic radius. This all encompassing 
model would be an ideal reference for creating a gel with predetermined properties and 
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